| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Multiple Sclerosis | 271 | 2025 | 3229 | 14.080 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 113 | 2022 | 820 | 10.280 |
Why?
|
| Immune Tolerance | 113 | 2024 | 2328 | 7.610 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 47 | 2024 | 551 | 5.540 |
Why?
|
| T-Lymphocytes, Regulatory | 72 | 2024 | 3114 | 5.090 |
Why?
|
| Multiple Sclerosis, Chronic Progressive | 30 | 2024 | 253 | 5.010 |
Why?
|
| Tuberous Sclerosis | 45 | 2023 | 1039 | 4.970 |
Why?
|
| Aldehyde Dehydrogenase | 57 | 2007 | 146 | 4.440 |
Why?
|
| Transforming Growth Factor beta | 56 | 2018 | 1996 | 4.090 |
Why?
|
| Interleukin-10 | 41 | 2020 | 1182 | 3.840 |
Why?
|
| Microglia | 29 | 2025 | 1370 | 3.840 |
Why?
|
| Autoimmune Diseases | 62 | 2023 | 2255 | 3.780 |
Why?
|
| Epilepsy | 41 | 2024 | 3317 | 3.500 |
Why?
|
| CD4-Positive T-Lymphocytes | 49 | 2022 | 4410 | 3.080 |
Why?
|
| Autoantigens | 40 | 2022 | 890 | 2.980 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 26 | 2018 | 975 | 2.940 |
Why?
|
| Mitochondria, Liver | 41 | 2000 | 190 | 2.940 |
Why?
|
| Dendritic Cells | 23 | 2024 | 2747 | 2.790 |
Why?
|
| T-Lymphocytes | 144 | 2024 | 10263 | 2.790 |
Why?
|
| Interleukin-17 | 22 | 2024 | 923 | 2.770 |
Why?
|
| Neurosurgical Procedures | 27 | 2024 | 2077 | 2.660 |
Why?
|
| Interferon-gamma | 47 | 2017 | 3157 | 2.590 |
Why?
|
| Administration, Oral | 114 | 2022 | 4019 | 2.450 |
Why?
|
| Transforming Growth Factor beta1 | 13 | 2023 | 637 | 2.420 |
Why?
|
| T-Lymphocyte Subsets | 28 | 2023 | 1814 | 2.390 |
Why?
|
| MicroRNAs | 22 | 2023 | 3789 | 2.300 |
Why?
|
| Antibodies, Monoclonal | 66 | 2023 | 9244 | 2.290 |
Why?
|
| Lymphocyte Activation | 89 | 2024 | 5502 | 2.090 |
Why?
|
| Interferon-beta | 16 | 2022 | 348 | 2.070 |
Why?
|
| Antigens | 30 | 2016 | 1442 | 1.990 |
Why?
|
| Immunosuppressive Agents | 42 | 2021 | 4215 | 1.940 |
Why?
|
| Animals | 430 | 2025 | 168939 | 1.930 |
Why?
|
| Immunologic Factors | 14 | 2021 | 1594 | 1.920 |
Why?
|
| Autoimmunity | 22 | 2022 | 1361 | 1.880 |
Why?
|
| Cytokines | 57 | 2024 | 7438 | 1.760 |
Why?
|
| Mice | 231 | 2025 | 81898 | 1.750 |
Why?
|
| Intestinal Mucosa | 18 | 2024 | 3041 | 1.710 |
Why?
|
| Brain | 124 | 2025 | 27158 | 1.700 |
Why?
|
| Adjuvants, Immunologic | 21 | 2022 | 996 | 1.660 |
Why?
|
| Forkhead Transcription Factors | 21 | 2018 | 1627 | 1.620 |
Why?
|
| Receptors, Aryl Hydrocarbon | 9 | 2019 | 221 | 1.620 |
Why?
|
| Immunity, Mucosal | 21 | 2024 | 498 | 1.610 |
Why?
|
| Muromonab-CD3 | 4 | 2022 | 104 | 1.560 |
Why?
|
| Monocytes | 21 | 2023 | 2599 | 1.530 |
Why?
|
| Alzheimer Disease | 28 | 2025 | 8715 | 1.490 |
Why?
|
| Th17 Cells | 7 | 2024 | 790 | 1.480 |
Why?
|
| Cyclophosphamide | 24 | 2013 | 2234 | 1.470 |
Why?
|
| Mice, Transgenic | 48 | 2025 | 9546 | 1.400 |
Why?
|
| Administration, Intranasal | 18 | 2023 | 482 | 1.400 |
Why?
|
| Neurofilament Proteins | 9 | 2024 | 335 | 1.390 |
Why?
|
| Humans | 688 | 2025 | 766812 | 1.390 |
Why?
|
| Central Nervous System | 21 | 2023 | 1345 | 1.370 |
Why?
|
| Homeostasis | 9 | 2024 | 3343 | 1.350 |
Why?
|
| Immunotherapy | 27 | 2018 | 4747 | 1.340 |
Why?
|
| Peyer's Patches | 14 | 2015 | 120 | 1.320 |
Why?
|
| Central Nervous System Diseases | 9 | 2020 | 518 | 1.320 |
Why?
|
| Amyotrophic Lateral Sclerosis | 9 | 2024 | 1481 | 1.290 |
Why?
|
| Peptides | 28 | 2014 | 4347 | 1.280 |
Why?
|
| Epilepsies, Partial | 8 | 2018 | 431 | 1.270 |
Why?
|
| Amyloid beta-Peptides | 17 | 2024 | 3886 | 1.250 |
Why?
|
| Vagus Nerve Stimulation | 6 | 2024 | 228 | 1.240 |
Why?
|
| Mice, Inbred C57BL | 72 | 2025 | 22351 | 1.240 |
Why?
|
| Th2 Cells | 18 | 2010 | 1077 | 1.220 |
Why?
|
| Interleukin-4 | 23 | 2003 | 1156 | 1.210 |
Why?
|
| Disease Models, Animal | 45 | 2025 | 18329 | 1.200 |
Why?
|
| Neuroglia | 7 | 2024 | 960 | 1.200 |
Why?
|
| Protein Sorting Signals | 13 | 2010 | 274 | 1.180 |
Why?
|
| Seizures | 21 | 2023 | 2996 | 1.160 |
Why?
|
| Receptors, Interleukin-2 | 11 | 2006 | 565 | 1.160 |
Why?
|
| Supratentorial Neoplasms | 2 | 2023 | 156 | 1.090 |
Why?
|
| Brain Neoplasms | 25 | 2024 | 9101 | 1.090 |
Why?
|
| Female | 400 | 2025 | 396532 | 1.080 |
Why?
|
| Dietary Proteins | 3 | 2024 | 960 | 1.070 |
Why?
|
| Magnetic Resonance Imaging | 109 | 2024 | 36570 | 1.070 |
Why?
|
| Astrocytes | 10 | 2021 | 1351 | 1.070 |
Why?
|
| Ovalbumin | 23 | 2018 | 677 | 1.060 |
Why?
|
| Interleukins | 6 | 2012 | 796 | 1.060 |
Why?
|
| CD8-Positive T-Lymphocytes | 14 | 2024 | 4652 | 1.050 |
Why?
|
| Protein Precursors | 5 | 2010 | 1134 | 1.040 |
Why?
|
| Male | 350 | 2025 | 364154 | 1.040 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 8 | 2015 | 306 | 1.020 |
Why?
|
| Hemispherectomy | 5 | 2024 | 40 | 1.020 |
Why?
|
| Baclofen | 7 | 2016 | 121 | 1.010 |
Why?
|
| Muscle Relaxants, Central | 5 | 2016 | 94 | 1.000 |
Why?
|
| Cell Differentiation | 27 | 2024 | 11657 | 1.000 |
Why?
|
| Peptide Fragments | 29 | 2020 | 5143 | 1.000 |
Why?
|
| Disease Progression | 50 | 2024 | 13642 | 1.000 |
Why?
|
| Epstein-Barr Virus Infections | 2 | 2022 | 617 | 1.000 |
Why?
|
| Spinal Cord | 14 | 2023 | 1811 | 0.990 |
Why?
|
| Cells, Cultured | 62 | 2024 | 18986 | 0.980 |
Why?
|
| Stereotaxic Techniques | 5 | 2024 | 551 | 0.970 |
Why?
|
| Electroencephalography | 33 | 2024 | 6282 | 0.960 |
Why?
|
| Th1 Cells | 16 | 2022 | 1040 | 0.960 |
Why?
|
| Autoantibodies | 19 | 2022 | 2115 | 0.960 |
Why?
|
| Demyelinating Diseases | 15 | 2017 | 354 | 0.950 |
Why?
|
| Neurosurgery | 5 | 2024 | 682 | 0.950 |
Why?
|
| Inflammation | 30 | 2024 | 10863 | 0.940 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 4 | 2023 | 354 | 0.940 |
Why?
|
| Receptors, Chemokine | 7 | 2021 | 652 | 0.940 |
Why?
|
| Disability Evaluation | 23 | 2021 | 1828 | 0.910 |
Why?
|
| Astrocytoma | 11 | 2020 | 773 | 0.900 |
Why?
|
| Receptors, Antigen, T-Cell | 33 | 2021 | 2571 | 0.900 |
Why?
|
| Probiotics | 2 | 2018 | 387 | 0.890 |
Why?
|
| Encephalitis | 10 | 2022 | 441 | 0.890 |
Why?
|
| Cerebellar Diseases | 3 | 2022 | 227 | 0.880 |
Why?
|
| Adult | 245 | 2025 | 223305 | 0.870 |
Why?
|
| Adoptive Transfer | 15 | 2021 | 828 | 0.860 |
Why?
|
| Nasal Mucosa | 7 | 2011 | 416 | 0.860 |
Why?
|
| Acetanilides | 3 | 2021 | 168 | 0.850 |
Why?
|
| Neurodegenerative Diseases | 4 | 2022 | 1089 | 0.840 |
Why?
|
| Plaque, Amyloid | 7 | 2025 | 769 | 0.830 |
Why?
|
| Psychosurgery | 1 | 2023 | 86 | 0.820 |
Why?
|
| Hydrocephalus | 12 | 2022 | 766 | 0.810 |
Why?
|
| Rats, Inbred Lew | 39 | 2012 | 1168 | 0.800 |
Why?
|
| Malformations of Cortical Development | 3 | 2022 | 174 | 0.800 |
Why?
|
| Atrophy | 23 | 2021 | 1631 | 0.800 |
Why?
|
| Myelin Proteins | 21 | 2009 | 212 | 0.790 |
Why?
|
| Positron-Emission Tomography | 9 | 2024 | 6548 | 0.780 |
Why?
|
| Medulloblastoma | 7 | 2024 | 679 | 0.780 |
Why?
|
| Feces | 6 | 2021 | 1505 | 0.780 |
Why?
|
| Electrodes, Implanted | 8 | 2024 | 835 | 0.780 |
Why?
|
| Muscle Spasticity | 5 | 2016 | 159 | 0.780 |
Why?
|
| Antibodies | 11 | 2011 | 2421 | 0.770 |
Why?
|
| Uveitis | 7 | 2022 | 398 | 0.770 |
Why?
|
| Child | 100 | 2024 | 80670 | 0.770 |
Why?
|
| Neurocutaneous Syndromes | 1 | 2022 | 53 | 0.760 |
Why?
|
| Laser Therapy | 3 | 2024 | 1108 | 0.760 |
Why?
|
| Cerebral Cortex | 22 | 2022 | 5753 | 0.760 |
Why?
|
| Mice, Knockout | 32 | 2024 | 14473 | 0.760 |
Why?
|
| Clonal Anergy | 8 | 2007 | 169 | 0.750 |
Why?
|
| Immunity, Innate | 14 | 2017 | 3079 | 0.750 |
Why?
|
| Phagocytosis | 5 | 2024 | 1526 | 0.750 |
Why?
|
| Middle Aged | 201 | 2025 | 223267 | 0.740 |
Why?
|
| Child, Preschool | 71 | 2024 | 42577 | 0.740 |
Why?
|
| Upstream Stimulatory Factors | 1 | 2020 | 18 | 0.730 |
Why?
|
| Cerebellar Neoplasms | 7 | 2024 | 588 | 0.720 |
Why?
|
| Fatigue | 8 | 2021 | 1555 | 0.710 |
Why?
|
| Up-Regulation | 15 | 2016 | 4143 | 0.700 |
Why?
|
| Apyrase | 3 | 2019 | 376 | 0.690 |
Why?
|
| B-Lymphocytes | 23 | 2022 | 4787 | 0.690 |
Why?
|
| Antigen-Presenting Cells | 14 | 2015 | 960 | 0.690 |
Why?
|
| Colitis | 6 | 2021 | 1238 | 0.680 |
Why?
|
| Rats | 108 | 2018 | 23717 | 0.680 |
Why?
|
| Chemokines, C | 1 | 2019 | 10 | 0.680 |
Why?
|
| RNA, Ribosomal, 16S | 3 | 2024 | 1044 | 0.670 |
Why?
|
| Osteopontin | 3 | 2013 | 305 | 0.670 |
Why?
|
| Diabetes Mellitus, Type 1 | 13 | 2016 | 3446 | 0.670 |
Why?
|
| Mouth Mucosa | 5 | 2011 | 434 | 0.660 |
Why?
|
| Arthritis, Experimental | 7 | 2010 | 293 | 0.660 |
Why?
|
| Lymph Nodes | 22 | 2019 | 3468 | 0.650 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 17 | 2010 | 897 | 0.650 |
Why?
|
| Hypersensitivity, Delayed | 20 | 2011 | 491 | 0.640 |
Why?
|
| Superoxide Dismutase | 3 | 2022 | 596 | 0.640 |
Why?
|
| Antigens, CD | 24 | 2019 | 4033 | 0.640 |
Why?
|
| Interleukin-12 | 12 | 2006 | 581 | 0.630 |
Why?
|
| Hamartoma | 3 | 2018 | 235 | 0.630 |
Why?
|
| Inflammation Mediators | 4 | 2020 | 1889 | 0.630 |
Why?
|
| Copper | 1 | 2021 | 365 | 0.630 |
Why?
|
| Allergy and Immunology | 2 | 2017 | 170 | 0.630 |
Why?
|
| Quality of Life | 22 | 2023 | 13476 | 0.630 |
Why?
|
| Lipopolysaccharides | 10 | 2017 | 2215 | 0.630 |
Why?
|
| Hippocampus | 9 | 2024 | 3776 | 0.620 |
Why?
|
| Substantia Nigra | 1 | 2020 | 346 | 0.620 |
Why?
|
| Enzyme Precursors | 8 | 1996 | 166 | 0.610 |
Why?
|
| Severity of Illness Index | 33 | 2020 | 15912 | 0.610 |
Why?
|
| Glutamic Acid | 7 | 2013 | 1181 | 0.610 |
Why?
|
| Meningomyelocele | 3 | 2024 | 182 | 0.600 |
Why?
|
| Interleukin-2 | 18 | 2016 | 1895 | 0.600 |
Why?
|
| Reoviridae | 19 | 1987 | 162 | 0.590 |
Why?
|
| Bifidobacterium | 1 | 2018 | 99 | 0.580 |
Why?
|
| Cysteine Endopeptidases | 5 | 2013 | 542 | 0.580 |
Why?
|
| Glycoproteins | 8 | 2010 | 2201 | 0.580 |
Why?
|
| Spleen | 32 | 2012 | 2295 | 0.580 |
Why?
|
| Treatment Outcome | 65 | 2024 | 65286 | 0.570 |
Why?
|
| Models, Immunological | 10 | 2018 | 517 | 0.570 |
Why?
|
| Interferon Type I | 5 | 2018 | 568 | 0.570 |
Why?
|
| Glial Fibrillary Acidic Protein | 7 | 2024 | 564 | 0.570 |
Why?
|
| Infusion Pumps, Implantable | 4 | 2016 | 158 | 0.570 |
Why?
|
| Mice, Inbred NOD | 17 | 2016 | 1836 | 0.560 |
Why?
|
| Killer Cells, Natural | 15 | 2016 | 2209 | 0.560 |
Why?
|
| Amino Acid Sequence | 49 | 2021 | 13411 | 0.560 |
Why?
|
| Sjogren-Larsson Syndrome | 1 | 2016 | 2 | 0.560 |
Why?
|
| Cognition Disorders | 9 | 2020 | 3967 | 0.550 |
Why?
|
| Spinal Cord Neoplasms | 4 | 2023 | 263 | 0.550 |
Why?
|
| Microscopy, Confocal | 3 | 2019 | 1969 | 0.550 |
Why?
|
| Gene Expression Regulation | 19 | 2024 | 11924 | 0.540 |
Why?
|
| Down-Regulation | 8 | 2012 | 2931 | 0.530 |
Why?
|
| Longitudinal Studies | 40 | 2025 | 14762 | 0.530 |
Why?
|
| Macrophages | 13 | 2019 | 5784 | 0.510 |
Why?
|
| Immunomodulation | 4 | 2020 | 548 | 0.510 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 18 | 2013 | 3803 | 0.510 |
Why?
|
| Macrophage Activation | 3 | 2017 | 554 | 0.510 |
Why?
|
| Mice, Inbred Strains | 23 | 2009 | 1767 | 0.510 |
Why?
|
| Retrospective Studies | 70 | 2024 | 81657 | 0.510 |
Why?
|
| Self Tolerance | 4 | 2007 | 122 | 0.500 |
Why?
|
| Adolescent | 91 | 2024 | 88902 | 0.500 |
Why?
|
| Membrane Proteins | 10 | 2023 | 7869 | 0.500 |
Why?
|
| Mice, Inbred BALB C | 32 | 2011 | 6225 | 0.490 |
Why?
|
| Granzymes | 3 | 2016 | 278 | 0.490 |
Why?
|
| Cell Membrane | 10 | 2010 | 3642 | 0.480 |
Why?
|
| Neocortex | 2 | 2018 | 414 | 0.480 |
Why?
|
| Arthritis, Rheumatoid | 7 | 2020 | 3788 | 0.480 |
Why?
|
| Dyspepsia | 1 | 2016 | 115 | 0.480 |
Why?
|
| Signal Transduction | 24 | 2024 | 23618 | 0.480 |
Why?
|
| Coculture Techniques | 9 | 2015 | 1337 | 0.480 |
Why?
|
| Lymphoid Tissue | 8 | 2003 | 445 | 0.480 |
Why?
|
| Molecular Sequence Data | 51 | 2010 | 17609 | 0.480 |
Why?
|
| Methylprednisolone | 5 | 1999 | 387 | 0.470 |
Why?
|
| Somatosensory Cortex | 2 | 2018 | 506 | 0.470 |
Why?
|
| Interleukin-6 | 5 | 2021 | 3226 | 0.470 |
Why?
|
| Isoenzymes | 12 | 1999 | 1688 | 0.470 |
Why?
|
| Hypothalamic Diseases | 1 | 2015 | 132 | 0.470 |
Why?
|
| Aldehyde Oxidoreductases | 12 | 1993 | 88 | 0.450 |
Why?
|
| Port-Wine Stain | 1 | 2014 | 33 | 0.450 |
Why?
|
| Immunity, Humoral | 1 | 2018 | 609 | 0.450 |
Why?
|
| Cell Death | 2 | 2018 | 1676 | 0.450 |
Why?
|
| Neurons | 15 | 2024 | 9515 | 0.450 |
Why?
|
| Gene Expression Profiling | 11 | 2021 | 9528 | 0.440 |
Why?
|
| Flow Cytometry | 20 | 2018 | 5890 | 0.440 |
Why?
|
| Magnetic Resonance Imaging, Interventional | 1 | 2015 | 194 | 0.440 |
Why?
|
| Intestines | 8 | 2023 | 1904 | 0.440 |
Why?
|
| Infant | 46 | 2024 | 36459 | 0.440 |
Why?
|
| Lymphocytes | 20 | 2009 | 2606 | 0.440 |
Why?
|
| Cell Polarity | 3 | 2012 | 637 | 0.430 |
Why?
|
| Immunity | 6 | 2022 | 1002 | 0.430 |
Why?
|
| Receptors, Immunologic | 7 | 2024 | 1417 | 0.430 |
Why?
|
| Mutism | 2 | 2024 | 27 | 0.430 |
Why?
|
| Receptors, Virus | 13 | 1988 | 652 | 0.420 |
Why?
|
| Immunization | 15 | 2018 | 1218 | 0.420 |
Why?
|
| Vagus Nerve | 11 | 2023 | 458 | 0.420 |
Why?
|
| Dose-Response Relationship, Immunologic | 14 | 2009 | 361 | 0.410 |
Why?
|
| Reoviridae Infections | 9 | 1987 | 59 | 0.410 |
Why?
|
| Sturge-Weber Syndrome | 1 | 2014 | 89 | 0.410 |
Why?
|
| Nervous System Diseases | 7 | 2018 | 1659 | 0.410 |
Why?
|
| Mutagenesis, Site-Directed | 12 | 2000 | 1677 | 0.410 |
Why?
|
| Retinal Pigment Epithelium | 2 | 2018 | 309 | 0.410 |
Why?
|
| Interleukin-9 | 1 | 2012 | 62 | 0.400 |
Why?
|
| Adenosine | 1 | 2017 | 812 | 0.400 |
Why?
|
| Skull | 5 | 2019 | 819 | 0.400 |
Why?
|
| Myelin-Associated Glycoprotein | 11 | 2009 | 110 | 0.400 |
Why?
|
| Antibody Formation | 18 | 2018 | 1392 | 0.390 |
Why?
|
| Serum | 2 | 2010 | 206 | 0.390 |
Why?
|
| Receptors, Purinergic P2X7 | 1 | 2012 | 86 | 0.390 |
Why?
|
| Follow-Up Studies | 37 | 2024 | 39312 | 0.390 |
Why?
|
| Intestine, Small | 2 | 2016 | 1217 | 0.390 |
Why?
|
| Cytosol | 8 | 2000 | 887 | 0.380 |
Why?
|
| Epitopes | 18 | 2014 | 2526 | 0.380 |
Why?
|
| Interleukin-23 | 3 | 2024 | 202 | 0.380 |
Why?
|
| Mitochondria | 8 | 2000 | 3678 | 0.380 |
Why?
|
| Mitoxantrone | 5 | 2018 | 148 | 0.380 |
Why?
|
| Kinetics | 32 | 2014 | 6288 | 0.380 |
Why?
|
| Adrenocorticotropic Hormone | 11 | 1993 | 618 | 0.370 |
Why?
|
| Cattle | 24 | 2010 | 3815 | 0.370 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2014 | 696 | 0.370 |
Why?
|
| Lupus Erythematosus, Systemic | 4 | 2009 | 2160 | 0.370 |
Why?
|
| Young Adult | 48 | 2024 | 59939 | 0.370 |
Why?
|
| Autocrine Communication | 1 | 2012 | 168 | 0.370 |
Why?
|
| Leukocytes, Mononuclear | 11 | 2023 | 1852 | 0.370 |
Why?
|
| Insulin | 10 | 2007 | 6608 | 0.370 |
Why?
|
| Adenosine Triphosphate | 1 | 2017 | 2001 | 0.370 |
Why?
|
| Craniotomy | 5 | 2016 | 736 | 0.370 |
Why?
|
| Germinoma | 3 | 2010 | 132 | 0.370 |
Why?
|
| Myelin Sheath | 8 | 2012 | 650 | 0.360 |
Why?
|
| Cell Proliferation | 16 | 2017 | 10451 | 0.360 |
Why?
|
| Hematoma, Epidural, Cranial | 1 | 2011 | 59 | 0.360 |
Why?
|
| Vaccines | 4 | 2022 | 842 | 0.360 |
Why?
|
| Growth Inhibitors | 2 | 2009 | 375 | 0.360 |
Why?
|
| Immunologic Memory | 4 | 2024 | 1377 | 0.360 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 4 | 2000 | 1621 | 0.360 |
Why?
|
| Postoperative Complications | 19 | 2024 | 15831 | 0.360 |
Why?
|
| Cloning, Molecular | 16 | 1999 | 4168 | 0.350 |
Why?
|
| Acetaldehyde | 7 | 1998 | 39 | 0.350 |
Why?
|
| Thymus Gland | 6 | 2010 | 1266 | 0.350 |
Why?
|
| Protein Structure, Secondary | 7 | 2000 | 1211 | 0.350 |
Why?
|
| Recurrence | 26 | 2023 | 8507 | 0.350 |
Why?
|
| Pediatrics | 4 | 2024 | 3614 | 0.350 |
Why?
|
| Intracranial Hypotension | 1 | 2011 | 42 | 0.350 |
Why?
|
| Collagen | 5 | 1999 | 2635 | 0.350 |
Why?
|
| Protein Array Analysis | 1 | 2012 | 399 | 0.340 |
Why?
|
| Adaptation, Psychological | 8 | 2024 | 2662 | 0.340 |
Why?
|
| Program Evaluation | 1 | 2018 | 2504 | 0.340 |
Why?
|
| Collagen Type II | 1 | 2010 | 151 | 0.340 |
Why?
|
| Biological Assay | 3 | 2020 | 626 | 0.340 |
Why?
|
| Alzheimer Vaccines | 3 | 2004 | 25 | 0.330 |
Why?
|
| Gastrointestinal Tract | 1 | 2016 | 835 | 0.330 |
Why?
|
| Major Histocompatibility Complex | 14 | 2022 | 880 | 0.330 |
Why?
|
| Encephalomyelitis | 3 | 1999 | 37 | 0.330 |
Why?
|
| Amyloid | 2 | 2008 | 849 | 0.330 |
Why?
|
| Chemokine CCL2 | 7 | 2014 | 605 | 0.330 |
Why?
|
| Transforming Growth Factor beta2 | 1 | 2010 | 71 | 0.330 |
Why?
|
| Alkylating Agents | 2 | 2002 | 132 | 0.330 |
Why?
|
| Pneumonia | 1 | 2021 | 2161 | 0.330 |
Why?
|
| Myelin Proteolipid Protein | 12 | 2004 | 107 | 0.330 |
Why?
|
| Toll-Like Receptor 9 | 1 | 2010 | 197 | 0.330 |
Why?
|
| Neuropsychological Tests | 12 | 2025 | 7119 | 0.330 |
Why?
|
| HLA-DR Antigens | 8 | 2015 | 609 | 0.330 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2010 | 287 | 0.330 |
Why?
|
| Peptic Ulcer | 5 | 1996 | 214 | 0.320 |
Why?
|
| Immune System | 7 | 2015 | 800 | 0.320 |
Why?
|
| Giant Cell Tumors | 1 | 2009 | 89 | 0.320 |
Why?
|
| Receptors, Purinergic P2Y12 | 4 | 2018 | 117 | 0.320 |
Why?
|
| Desensitization, Immunologic | 4 | 1995 | 546 | 0.310 |
Why?
|
| Microarray Analysis | 3 | 2018 | 751 | 0.310 |
Why?
|
| Binding Sites | 20 | 2015 | 6013 | 0.310 |
Why?
|
| Monitoring, Physiologic | 5 | 2012 | 1794 | 0.300 |
Why?
|
| Neuromyelitis Optica | 1 | 2012 | 266 | 0.300 |
Why?
|
| Lymphocyte Depletion | 5 | 2010 | 606 | 0.300 |
Why?
|
| Optic Neuritis | 3 | 2021 | 173 | 0.300 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2010 | 434 | 0.300 |
Why?
|
| Clone Cells | 14 | 2021 | 1670 | 0.300 |
Why?
|
| Central Nervous System Neoplasms | 4 | 2021 | 926 | 0.300 |
Why?
|
| Antigens, Surface | 13 | 2009 | 1617 | 0.300 |
Why?
|
| Membrane Glycoproteins | 8 | 2017 | 3702 | 0.300 |
Why?
|
| Environment | 3 | 2015 | 1120 | 0.300 |
Why?
|
| Psychophysiologic Disorders | 6 | 1992 | 222 | 0.290 |
Why?
|
| Liver | 20 | 2010 | 7571 | 0.290 |
Why?
|
| Time Factors | 45 | 2020 | 40149 | 0.290 |
Why?
|
| Meningeal Neoplasms | 2 | 2014 | 1255 | 0.290 |
Why?
|
| NAD | 14 | 2000 | 617 | 0.290 |
Why?
|
| Organ Specificity | 8 | 2020 | 1968 | 0.290 |
Why?
|
| Gene Expression | 11 | 2021 | 7585 | 0.290 |
Why?
|
| Plasmapheresis | 6 | 1990 | 205 | 0.290 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2013 | 903 | 0.290 |
Why?
|
| Smad7 Protein | 2 | 2019 | 39 | 0.290 |
Why?
|
| Herpesvirus 4, Human | 4 | 2022 | 1080 | 0.290 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2009 | 428 | 0.290 |
Why?
|
| Tumor Necrosis Factor-alpha | 9 | 2020 | 4349 | 0.290 |
Why?
|
| Immunity, Cellular | 15 | 2003 | 1560 | 0.280 |
Why?
|
| Heat-Shock Proteins | 2 | 2010 | 792 | 0.280 |
Why?
|
| Meningocele | 2 | 2019 | 50 | 0.280 |
Why?
|
| Meningoencephalitis | 3 | 2006 | 82 | 0.280 |
Why?
|
| Sex Factors | 4 | 2024 | 10619 | 0.280 |
Why?
|
| Thrombospondin 1 | 1 | 2009 | 257 | 0.280 |
Why?
|
| Base Sequence | 23 | 2015 | 12415 | 0.280 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2009 | 347 | 0.280 |
Why?
|
| Interleukin-15 | 1 | 2008 | 186 | 0.280 |
Why?
|
| Antigen Presentation | 5 | 2009 | 1250 | 0.280 |
Why?
|
| Conserved Sequence | 5 | 2010 | 1159 | 0.280 |
Why?
|
| Receptors, Growth Factor | 3 | 2000 | 324 | 0.280 |
Why?
|
| Grief | 3 | 1996 | 256 | 0.280 |
Why?
|
| Cerebral Ventricle Neoplasms | 3 | 2015 | 43 | 0.280 |
Why?
|
| Inflammasomes | 1 | 2012 | 541 | 0.280 |
Why?
|
| Syringomyelia | 1 | 2007 | 66 | 0.280 |
Why?
|
| Injections, Spinal | 6 | 2016 | 317 | 0.270 |
Why?
|
| Immunophenotyping | 7 | 2015 | 1867 | 0.270 |
Why?
|
| Protein Biosynthesis | 12 | 1999 | 2093 | 0.270 |
Why?
|
| Immunization, Passive | 15 | 2001 | 618 | 0.270 |
Why?
|
| Aging | 14 | 2021 | 8728 | 0.270 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 3 | 2 | 2024 | 151 | 0.270 |
Why?
|
| Trans-Activators | 4 | 2005 | 2856 | 0.270 |
Why?
|
| Recovery of Function | 3 | 2020 | 2978 | 0.260 |
Why?
|
| Genetic Predisposition to Disease | 14 | 2022 | 18076 | 0.260 |
Why?
|
| Cell Communication | 6 | 2016 | 1660 | 0.260 |
Why?
|
| RNA, Messenger | 21 | 2017 | 12795 | 0.260 |
Why?
|
| Brain Chemistry | 5 | 2000 | 951 | 0.260 |
Why?
|
| Craniosynostoses | 5 | 2004 | 415 | 0.260 |
Why?
|
| Clinical Trials as Topic | 23 | 2016 | 8045 | 0.260 |
Why?
|
| Immunohistochemistry | 17 | 2018 | 11062 | 0.260 |
Why?
|
| Radiosurgery | 1 | 2015 | 1330 | 0.260 |
Why?
|
| Chemokines | 2 | 2008 | 963 | 0.260 |
Why?
|
| Ependymoma | 4 | 2023 | 326 | 0.260 |
Why?
|
| Quinolones | 2 | 2008 | 389 | 0.250 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 1 | 2006 | 102 | 0.250 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2009 | 483 | 0.250 |
Why?
|
| Methotrexate | 7 | 2013 | 1719 | 0.250 |
Why?
|
| Ethanol | 8 | 1998 | 1326 | 0.250 |
Why?
|
| Recombinant Proteins | 18 | 2011 | 6507 | 0.250 |
Why?
|
| Troponin | 1 | 2009 | 536 | 0.250 |
Why?
|
| Interferon Regulatory Factor-7 | 2 | 2018 | 36 | 0.250 |
Why?
|
| Thiosulfate Sulfurtransferase | 4 | 2000 | 10 | 0.250 |
Why?
|
| Immunotherapy, Adoptive | 7 | 2007 | 1503 | 0.250 |
Why?
|
| Zebrafish Proteins | 2 | 2010 | 1018 | 0.240 |
Why?
|
| Reoperation | 9 | 2019 | 4325 | 0.240 |
Why?
|
| Frontal Lobe | 3 | 2009 | 1408 | 0.240 |
Why?
|
| Bereavement | 5 | 1995 | 309 | 0.240 |
Why?
|
| Drainage | 1 | 2011 | 1182 | 0.240 |
Why?
|
| Hysterotomy | 1 | 2024 | 25 | 0.240 |
Why?
|
| Freund's Adjuvant | 5 | 2018 | 144 | 0.240 |
Why?
|
| Cell Line | 17 | 2011 | 15564 | 0.240 |
Why?
|
| Diabetes Mellitus, Experimental | 2 | 2001 | 1121 | 0.240 |
Why?
|
| Lysine | 3 | 2000 | 998 | 0.240 |
Why?
|
| Plasma Exchange | 4 | 1989 | 160 | 0.230 |
Why?
|
| Molecular Weight | 9 | 2012 | 2168 | 0.230 |
Why?
|
| Prostaglandins E | 2 | 1995 | 166 | 0.230 |
Why?
|
| Cohort Studies | 26 | 2024 | 41706 | 0.230 |
Why?
|
| Brain Mapping | 9 | 2024 | 6597 | 0.230 |
Why?
|
| Mesentery | 3 | 2019 | 201 | 0.230 |
Why?
|
| Systems Biology | 1 | 2008 | 481 | 0.230 |
Why?
|
| Streptococcus anginosus | 1 | 2024 | 25 | 0.230 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2008 | 1319 | 0.230 |
Why?
|
| Xenon | 1 | 2025 | 120 | 0.230 |
Why?
|
| Mice, Mutant Strains | 5 | 2018 | 1751 | 0.230 |
Why?
|
| Neuroprotective Agents | 2 | 2008 | 956 | 0.230 |
Why?
|
| Receptors, CXCR5 | 2 | 2018 | 88 | 0.230 |
Why?
|
| Hippurates | 1 | 2024 | 15 | 0.230 |
Why?
|
| Mice, Inbred NZB | 3 | 2009 | 57 | 0.230 |
Why?
|
| Phenotype | 23 | 2020 | 16722 | 0.230 |
Why?
|
| Carrier Proteins | 2 | 2012 | 4926 | 0.230 |
Why?
|
| Mice, Inbred DBA | 6 | 2019 | 624 | 0.230 |
Why?
|
| Gene Targeting | 2 | 2017 | 841 | 0.230 |
Why?
|
| Mastoiditis | 1 | 2024 | 37 | 0.230 |
Why?
|
| Graft Rejection | 5 | 2017 | 4504 | 0.220 |
Why?
|
| Ataxia | 3 | 2018 | 307 | 0.220 |
Why?
|
| Life Change Events | 5 | 1995 | 956 | 0.220 |
Why?
|
| Pilot Projects | 13 | 2021 | 8728 | 0.220 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 1 | 2024 | 175 | 0.220 |
Why?
|
| Analysis of Variance | 8 | 2013 | 6214 | 0.220 |
Why?
|
| Skin Transplantation | 4 | 2017 | 1097 | 0.220 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2006 | 462 | 0.220 |
Why?
|
| Fetoscopy | 1 | 2024 | 140 | 0.220 |
Why?
|
| Vaccination | 9 | 2022 | 3435 | 0.220 |
Why?
|
| Neuroendoscopy | 2 | 2015 | 100 | 0.220 |
Why?
|
| Stress, Psychological | 13 | 1996 | 4526 | 0.210 |
Why?
|
| Glioma | 6 | 2010 | 3498 | 0.210 |
Why?
|
| Spinal Cord Injuries | 5 | 2020 | 927 | 0.210 |
Why?
|
| CD40 Ligand | 3 | 2002 | 528 | 0.210 |
Why?
|
| Brain Abscess | 1 | 2024 | 122 | 0.210 |
Why?
|
| Poliovirus | 3 | 1988 | 106 | 0.210 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 6 | 2016 | 4570 | 0.210 |
Why?
|
| Leukocytes | 5 | 2004 | 2034 | 0.210 |
Why?
|
| Glycolipids | 2 | 2014 | 203 | 0.210 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 3 | 2010 | 497 | 0.210 |
Why?
|
| Cerebrovascular Trauma | 1 | 2023 | 21 | 0.210 |
Why?
|
| Oligodendroglia | 3 | 2021 | 539 | 0.210 |
Why?
|
| Bacteroides fragilis | 1 | 2024 | 250 | 0.200 |
Why?
|
| Chaperonins | 1 | 2002 | 58 | 0.200 |
Why?
|
| Prospective Studies | 25 | 2023 | 54872 | 0.200 |
Why?
|
| Gadolinium | 7 | 2023 | 964 | 0.200 |
Why?
|
| Brain Stem | 4 | 1999 | 858 | 0.200 |
Why?
|
| Glomerulonephritis | 2 | 2018 | 333 | 0.200 |
Why?
|
| Interferons | 4 | 2022 | 716 | 0.200 |
Why?
|
| Azathioprine | 4 | 2013 | 354 | 0.200 |
Why?
|
| Laparotomy | 1 | 2024 | 459 | 0.200 |
Why?
|
| Brain Infarction | 3 | 2017 | 285 | 0.200 |
Why?
|
| Leukocyte Count | 10 | 2017 | 1606 | 0.200 |
Why?
|
| Antibodies, Anti-Idiotypic | 8 | 1988 | 347 | 0.200 |
Why?
|
| Saccharomyces cerevisiae | 4 | 2000 | 2678 | 0.200 |
Why?
|
| Ventriculoperitoneal Shunt | 4 | 2009 | 186 | 0.200 |
Why?
|
| Nose | 1 | 2006 | 522 | 0.200 |
Why?
|
| Lymphotoxin-alpha | 6 | 2002 | 94 | 0.200 |
Why?
|
| Intracranial Pressure | 2 | 2015 | 323 | 0.190 |
Why?
|
| Immunoglobulin mu-Chains | 2 | 2001 | 62 | 0.190 |
Why?
|
| Immunoglobulin G | 14 | 2020 | 4559 | 0.190 |
Why?
|
| Demyelinating Autoimmune Diseases, CNS | 1 | 2022 | 40 | 0.190 |
Why?
|
| Arteriosclerosis | 2 | 2004 | 1055 | 0.190 |
Why?
|
| Cerebrospinal Fluid | 8 | 2005 | 540 | 0.190 |
Why?
|
| Otitis Media | 1 | 2024 | 287 | 0.190 |
Why?
|
| Drug Therapy, Combination | 13 | 2010 | 6306 | 0.190 |
Why?
|
| Disabled Persons | 5 | 2020 | 1209 | 0.190 |
Why?
|
| Oncogene Proteins | 2 | 2002 | 715 | 0.190 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 3 | 2013 | 258 | 0.190 |
Why?
|
| Tumor Suppressor Proteins | 3 | 2014 | 2801 | 0.190 |
Why?
|
| Calcium | 2 | 2013 | 5783 | 0.190 |
Why?
|
| Isoantigens | 4 | 2008 | 562 | 0.190 |
Why?
|
| Craniofacial Abnormalities | 1 | 2004 | 320 | 0.190 |
Why?
|
| Antigens, Differentiation | 5 | 2006 | 921 | 0.190 |
Why?
|
| Home Infusion Therapy | 1 | 2001 | 18 | 0.190 |
Why?
|
| Protein-Tyrosine Kinases | 3 | 2000 | 2426 | 0.190 |
Why?
|
| Biological Transport | 8 | 2013 | 2083 | 0.180 |
Why?
|
| Lymphopenia | 2 | 2017 | 300 | 0.180 |
Why?
|
| rho-Associated Kinases | 1 | 2023 | 290 | 0.180 |
Why?
|
| Transplantation, Homologous | 5 | 2008 | 4860 | 0.180 |
Why?
|
| Diffusion Tensor Imaging | 2 | 2023 | 2419 | 0.180 |
Why?
|
| Aged | 56 | 2024 | 171344 | 0.180 |
Why?
|
| Tauopathies | 1 | 2025 | 325 | 0.180 |
Why?
|
| Receptors, Mitogen | 1 | 2000 | 61 | 0.180 |
Why?
|
| Gliosis | 2 | 2015 | 246 | 0.180 |
Why?
|
| Multiple System Atrophy | 1 | 2022 | 132 | 0.180 |
Why?
|
| Endorphins | 2 | 1992 | 73 | 0.180 |
Why?
|
| T Cell Transcription Factor 1 | 2 | 2024 | 72 | 0.180 |
Why?
|
| Species Specificity | 12 | 2003 | 2413 | 0.180 |
Why?
|
| Amyloid beta-Protein Precursor | 3 | 2017 | 1117 | 0.180 |
Why?
|
| Putamen | 1 | 2022 | 288 | 0.180 |
Why?
|
| Mast Cells | 5 | 2012 | 1405 | 0.180 |
Why?
|
| Ligands | 6 | 2012 | 3274 | 0.180 |
Why?
|
| Stem Cell Transplantation | 2 | 2008 | 1600 | 0.180 |
Why?
|
| Hypothalamo-Hypophyseal System | 3 | 2018 | 702 | 0.180 |
Why?
|
| Abortion, Spontaneous | 2 | 1996 | 536 | 0.180 |
Why?
|
| Thyrotropin-Releasing Hormone | 11 | 1995 | 139 | 0.180 |
Why?
|
| Myasthenia Gravis | 3 | 1999 | 214 | 0.180 |
Why?
|
| Language Development Disorders | 1 | 2022 | 194 | 0.180 |
Why?
|
| Cell Division | 11 | 2003 | 4473 | 0.180 |
Why?
|
| Auditory Cortex | 1 | 2024 | 366 | 0.180 |
Why?
|
| Age of Onset | 8 | 2021 | 3343 | 0.180 |
Why?
|
| Vitamins | 1 | 2009 | 1631 | 0.180 |
Why?
|
| Immunoconjugates | 3 | 2008 | 976 | 0.180 |
Why?
|
| Receptors, CCR6 | 1 | 2020 | 73 | 0.180 |
Why?
|
| Toluidines | 1 | 2020 | 21 | 0.180 |
Why?
|
| Crotonates | 1 | 2020 | 21 | 0.180 |
Why?
|
| Sequence Homology, Amino Acid | 6 | 2010 | 2746 | 0.180 |
Why?
|
| Receptors, CXCR3 | 2 | 2020 | 240 | 0.170 |
Why?
|
| Duodenal Diseases | 2 | 1998 | 101 | 0.170 |
Why?
|
| Interleukin-18 | 1 | 2002 | 251 | 0.170 |
Why?
|
| Antigens, Ly | 4 | 2012 | 297 | 0.170 |
Why?
|
| Apolipoproteins E | 2 | 2017 | 1459 | 0.170 |
Why?
|
| DNA | 16 | 2009 | 7210 | 0.170 |
Why?
|
| Apoptosis | 9 | 2017 | 9514 | 0.170 |
Why?
|
| Hemodynamics | 1 | 2011 | 4188 | 0.170 |
Why?
|
| Gastric Acid | 6 | 1996 | 98 | 0.170 |
Why?
|
| Multiple Trauma | 1 | 2023 | 369 | 0.170 |
Why?
|
| Liposomes | 4 | 1999 | 787 | 0.170 |
Why?
|
| Chickens | 3 | 2018 | 843 | 0.170 |
Why?
|
| Receptors, GABA | 2 | 2022 | 312 | 0.170 |
Why?
|
| Albuterol | 3 | 2010 | 211 | 0.170 |
Why?
|
| Genes, T-Cell Receptor delta | 1 | 2019 | 10 | 0.170 |
Why?
|
| Prognosis | 20 | 2021 | 29959 | 0.170 |
Why?
|
| Axons | 1 | 2008 | 1675 | 0.170 |
Why?
|
| Spasms, Infantile | 1 | 2023 | 300 | 0.170 |
Why?
|
| Arginine | 3 | 2013 | 932 | 0.170 |
Why?
|
| Receptors, LDL | 1 | 2002 | 492 | 0.170 |
Why?
|
| Apolipoprotein E4 | 1 | 2024 | 709 | 0.170 |
Why?
|
| Nerve Fibers, Myelinated | 3 | 2011 | 951 | 0.170 |
Why?
|
| Injections, Intravenous | 10 | 2005 | 1377 | 0.170 |
Why?
|
| Mesencephalon | 1 | 2022 | 337 | 0.170 |
Why?
|
| Speech Perception | 1 | 2024 | 512 | 0.170 |
Why?
|
| Image Interpretation, Computer-Assisted | 6 | 2019 | 3360 | 0.170 |
Why?
|
| Speech | 1 | 2024 | 555 | 0.170 |
Why?
|
| Lactase | 1 | 2019 | 72 | 0.170 |
Why?
|
| International Cooperation | 3 | 2018 | 1434 | 0.170 |
Why?
|
| Integrins | 2 | 2011 | 839 | 0.160 |
Why?
|
| Cycloheximide | 1 | 1999 | 340 | 0.160 |
Why?
|
| Cell Movement | 10 | 2019 | 5204 | 0.160 |
Why?
|
| Neoplasms, Complex and Mixed | 1 | 1999 | 35 | 0.160 |
Why?
|
| Streptococcal Infections | 1 | 2024 | 618 | 0.160 |
Why?
|
| Myeloid Cells | 2 | 2017 | 838 | 0.160 |
Why?
|
| Mammalian orthoreovirus 3 | 11 | 1986 | 45 | 0.160 |
Why?
|
| Protein Conformation | 11 | 1999 | 3948 | 0.160 |
Why?
|
| Alcohol Dehydrogenase | 1 | 1999 | 113 | 0.160 |
Why?
|
| Epithelial Cells | 2 | 2010 | 3698 | 0.160 |
Why?
|
| Guinea Pigs | 9 | 2001 | 1309 | 0.160 |
Why?
|
| Perioperative Period | 1 | 2020 | 252 | 0.160 |
Why?
|
| RNA, Small Interfering | 4 | 2020 | 3427 | 0.160 |
Why?
|
| Panama | 1 | 2018 | 28 | 0.160 |
Why?
|
| Seasons | 2 | 2010 | 1519 | 0.160 |
Why?
|
| Linoleic Acids, Conjugated | 1 | 2018 | 13 | 0.160 |
Why?
|
| Infratentorial Neoplasms | 1 | 2020 | 99 | 0.160 |
Why?
|
| Rotarod Performance Test | 1 | 2018 | 63 | 0.160 |
Why?
|
| Lymphocyte Culture Test, Mixed | 7 | 1995 | 511 | 0.160 |
Why?
|
| Stomach Diseases | 2 | 1998 | 134 | 0.160 |
Why?
|
| Hydrocephalus, Normal Pressure | 2 | 2000 | 101 | 0.160 |
Why?
|
| Subcellular Fractions | 4 | 2011 | 526 | 0.160 |
Why?
|
| Injections, Subcutaneous | 5 | 2016 | 684 | 0.160 |
Why?
|
| Alum Compounds | 1 | 2018 | 35 | 0.160 |
Why?
|
| Adrenoleukodystrophy | 1 | 2001 | 144 | 0.160 |
Why?
|
| Receptors, Cholinergic | 1 | 1999 | 243 | 0.160 |
Why?
|
| Models, Statistical | 5 | 2016 | 5092 | 0.160 |
Why?
|
| DNA, Complementary | 7 | 2004 | 1989 | 0.150 |
Why?
|
| Intermediate Filaments | 3 | 2023 | 171 | 0.150 |
Why?
|
| GTP-Binding Proteins | 1 | 2023 | 946 | 0.150 |
Why?
|
| Proto-Oncogene Proteins c-maf | 1 | 2018 | 69 | 0.150 |
Why?
|
| Phosphatidylcholines | 1 | 2020 | 404 | 0.150 |
Why?
|
| Mouth | 4 | 2006 | 383 | 0.150 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2000 | 170 | 0.150 |
Why?
|
| Adaptive Immunity | 2 | 2015 | 734 | 0.150 |
Why?
|
| Cerebrospinal Fluid Shunts | 3 | 2001 | 197 | 0.150 |
Why?
|
| Kynurenine | 1 | 2019 | 142 | 0.150 |
Why?
|
| Endoscopy | 5 | 2015 | 1854 | 0.150 |
Why?
|
| Horses | 14 | 1989 | 294 | 0.150 |
Why?
|
| Glutamate Decarboxylase | 1 | 1999 | 239 | 0.150 |
Why?
|
| Terminology as Topic | 2 | 2024 | 1540 | 0.150 |
Why?
|
| 5' Untranslated Regions | 1 | 1999 | 255 | 0.150 |
Why?
|
| Chaperonin 60 | 2 | 2012 | 97 | 0.150 |
Why?
|
| Receptor, Interferon alpha-beta | 1 | 2018 | 113 | 0.150 |
Why?
|
| Adipose Tissue | 1 | 2010 | 3317 | 0.150 |
Why?
|
| Receptors, Tumor Necrosis Factor | 2 | 2002 | 588 | 0.150 |
Why?
|
| Proteomics | 4 | 2024 | 3915 | 0.150 |
Why?
|
| Antineoplastic Agents | 5 | 2018 | 13644 | 0.150 |
Why?
|
| Meninges | 1 | 2019 | 197 | 0.150 |
Why?
|
| Helicobacter pylori | 2 | 1998 | 380 | 0.150 |
Why?
|
| Skull Neoplasms | 1 | 1999 | 173 | 0.150 |
Why?
|
| Sensitivity and Specificity | 11 | 2017 | 14653 | 0.150 |
Why?
|
| Dystonia | 1 | 2001 | 378 | 0.150 |
Why?
|
| Bacteria | 4 | 2024 | 2212 | 0.150 |
Why?
|
| Proteolipids | 3 | 1995 | 109 | 0.150 |
Why?
|
| Cytarabine | 2 | 2018 | 696 | 0.150 |
Why?
|
| Neoplasm Recurrence, Local | 8 | 2023 | 9407 | 0.150 |
Why?
|
| Nitric Oxide | 2 | 2003 | 2140 | 0.150 |
Why?
|
| Ependyma | 6 | 1984 | 57 | 0.150 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2019 | 262 | 0.140 |
Why?
|
| Optic Nerve | 2 | 2020 | 568 | 0.140 |
Why?
|
| Histocompatibility Antigens Class II | 7 | 2001 | 1442 | 0.140 |
Why?
|
| Depressive Disorder | 6 | 2009 | 3715 | 0.140 |
Why?
|
| Animals, Newborn | 6 | 2013 | 2677 | 0.140 |
Why?
|
| Blood-Brain Barrier | 6 | 2013 | 1028 | 0.140 |
Why?
|
| Minocycline | 1 | 2018 | 170 | 0.140 |
Why?
|
| Lymphocyte Subsets | 4 | 2004 | 313 | 0.140 |
Why?
|
| Predictive Value of Tests | 12 | 2015 | 15425 | 0.140 |
Why?
|
| STAT3 Transcription Factor | 3 | 2019 | 872 | 0.140 |
Why?
|
| Skull Fractures | 1 | 1999 | 202 | 0.140 |
Why?
|
| Social Support | 3 | 2020 | 2191 | 0.140 |
Why?
|
| Caloric Restriction | 1 | 2019 | 303 | 0.140 |
Why?
|
| Hemagglutinins, Viral | 9 | 1986 | 66 | 0.140 |
Why?
|
| Cell Compartmentation | 3 | 2010 | 383 | 0.140 |
Why?
|
| Recombinant Fusion Proteins | 5 | 2002 | 3738 | 0.140 |
Why?
|
| Administration, Mucosal | 1 | 2016 | 6 | 0.140 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2022 | 2887 | 0.140 |
Why?
|
| Kidney Glomerulus | 2 | 2018 | 571 | 0.140 |
Why?
|
| Wounds, Nonpenetrating | 2 | 2023 | 807 | 0.140 |
Why?
|
| Models, Biological | 8 | 2013 | 9464 | 0.140 |
Why?
|
| Acquired Immunodeficiency Syndrome | 4 | 1997 | 2204 | 0.140 |
Why?
|
| Spouses | 2 | 1996 | 286 | 0.140 |
Why?
|
| Fumarates | 1 | 2017 | 132 | 0.140 |
Why?
|
| Reference Values | 9 | 2009 | 4914 | 0.140 |
Why?
|
| Lactobacillus | 1 | 2018 | 212 | 0.140 |
Why?
|
| Dura Mater | 1 | 1999 | 292 | 0.140 |
Why?
|
| Genotype | 9 | 2021 | 13036 | 0.140 |
Why?
|
| RNA | 3 | 2018 | 2715 | 0.140 |
Why?
|
| Wine | 1 | 2017 | 172 | 0.130 |
Why?
|
| Spinal Osteophytosis | 2 | 1993 | 30 | 0.130 |
Why?
|
| Photoreceptor Cells, Vertebrate | 1 | 2018 | 203 | 0.130 |
Why?
|
| Methane | 1 | 2016 | 44 | 0.130 |
Why?
|
| Virology | 1 | 2016 | 76 | 0.130 |
Why?
|
| Gene Knockout Techniques | 1 | 2019 | 804 | 0.130 |
Why?
|
| Point Mutation | 4 | 2003 | 1592 | 0.130 |
Why?
|
| Fluorine Radioisotopes | 1 | 2019 | 405 | 0.130 |
Why?
|
| Receptors, CCR2 | 4 | 2014 | 215 | 0.130 |
Why?
|
| Magnesium | 6 | 1987 | 815 | 0.130 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2000 | 1057 | 0.130 |
Why?
|
| Animals, Congenic | 1 | 2015 | 27 | 0.130 |
Why?
|
| Leukemia, Radiation-Induced | 1 | 2015 | 36 | 0.130 |
Why?
|
| Rats, Inbred Strains | 17 | 1996 | 2078 | 0.130 |
Why?
|
| Insulin Resistance | 1 | 2010 | 3989 | 0.130 |
Why?
|
| Sample Size | 2 | 2017 | 844 | 0.130 |
Why?
|
| Computers | 1 | 2018 | 589 | 0.130 |
Why?
|
| Patient Selection | 5 | 2021 | 4252 | 0.130 |
Why?
|
| Aorta, Thoracic | 1 | 2002 | 1110 | 0.130 |
Why?
|
| STAT1 Transcription Factor | 2 | 2019 | 340 | 0.130 |
Why?
|
| AIDS Dementia Complex | 2 | 1994 | 154 | 0.130 |
Why?
|
| Caudate Nucleus | 2 | 2012 | 388 | 0.130 |
Why?
|
| Stomach Ulcer | 3 | 1983 | 118 | 0.130 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2016 | 200 | 0.130 |
Why?
|
| Pituitary-Adrenal System | 2 | 2018 | 553 | 0.130 |
Why?
|
| Nervous System | 4 | 2009 | 542 | 0.130 |
Why?
|
| Protease Inhibitors | 1 | 2019 | 750 | 0.130 |
Why?
|
| Hydrocortisone | 5 | 1992 | 1838 | 0.130 |
Why?
|
| Nervous System Neoplasms | 1 | 2016 | 91 | 0.130 |
Why?
|
| Reproducibility of Results | 12 | 2018 | 20146 | 0.130 |
Why?
|
| History, 20th Century | 4 | 2017 | 2764 | 0.130 |
Why?
|
| Anaphylaxis | 2 | 2013 | 738 | 0.130 |
Why?
|
| Magnetic Resonance Spectroscopy | 6 | 2023 | 3681 | 0.130 |
Why?
|
| Drug Resistance | 5 | 2011 | 1592 | 0.130 |
Why?
|
| Administration, Inhalation | 3 | 2025 | 1154 | 0.130 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 1999 | 1131 | 0.130 |
Why?
|
| Burnout, Professional | 1 | 2024 | 710 | 0.130 |
Why?
|
| PPAR gamma | 1 | 2018 | 484 | 0.130 |
Why?
|
| Histocompatibility Antigens | 3 | 1996 | 479 | 0.120 |
Why?
|
| Protective Agents | 1 | 2016 | 150 | 0.120 |
Why?
|
| Clonal Deletion | 1 | 1995 | 75 | 0.120 |
Why?
|
| Brain Edema | 1 | 2020 | 601 | 0.120 |
Why?
|
| Depression | 9 | 2020 | 8225 | 0.120 |
Why?
|
| Multicenter Studies as Topic | 5 | 2022 | 1733 | 0.120 |
Why?
|
| Immunoglobulin kappa-Chains | 2 | 1994 | 171 | 0.120 |
Why?
|
| Polymerase Chain Reaction | 7 | 2008 | 6066 | 0.120 |
Why?
|
| Activating Transcription Factor 3 | 1 | 2015 | 62 | 0.120 |
Why?
|
| Epitopes, T-Lymphocyte | 6 | 2012 | 827 | 0.120 |
Why?
|
| Immunoglobulin M | 7 | 2020 | 1527 | 0.120 |
Why?
|
| Case-Control Studies | 11 | 2024 | 22248 | 0.120 |
Why?
|
| Third Ventricle | 3 | 2015 | 78 | 0.120 |
Why?
|
| Arousal | 3 | 1998 | 1174 | 0.120 |
Why?
|
| Microsurgery | 3 | 2013 | 798 | 0.120 |
Why?
|
| Somatoform Disorders | 1 | 1998 | 425 | 0.120 |
Why?
|
| Oligoribonucleotides, Antisense | 1 | 2014 | 14 | 0.120 |
Why?
|
| Synaptic Transmission | 2 | 2013 | 1175 | 0.120 |
Why?
|
| Pneumonia, Pneumococcal | 1 | 2016 | 133 | 0.120 |
Why?
|
| Interleukin-7 Receptor alpha Subunit | 1 | 2015 | 50 | 0.120 |
Why?
|
| Breath Tests | 1 | 2016 | 297 | 0.120 |
Why?
|
| RNA Interference | 2 | 2015 | 2829 | 0.120 |
Why?
|
| Dexamethasone | 3 | 2020 | 1962 | 0.120 |
Why?
|
| Neuromuscular Diseases | 1 | 1997 | 260 | 0.120 |
Why?
|
| Bacterial Proteins | 2 | 2012 | 3833 | 0.120 |
Why?
|
| Protein Processing, Post-Translational | 3 | 2020 | 1965 | 0.120 |
Why?
|
| Syncope | 2 | 2023 | 431 | 0.120 |
Why?
|
| Helicobacter Infections | 1 | 1998 | 390 | 0.120 |
Why?
|
| Corticotropin-Releasing Hormone | 4 | 1991 | 362 | 0.120 |
Why?
|
| Drug Combinations | 4 | 2013 | 2085 | 0.120 |
Why?
|
| Sinusitis | 1 | 2024 | 997 | 0.120 |
Why?
|
| Leukoencephalopathy, Progressive Multifocal | 3 | 2011 | 133 | 0.120 |
Why?
|
| Ventriculostomy | 3 | 2015 | 132 | 0.120 |
Why?
|
| Lymphoma, B-Cell | 1 | 2021 | 945 | 0.120 |
Why?
|
| Steroids | 1 | 2020 | 936 | 0.120 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2012 | 3796 | 0.120 |
Why?
|
| Genes, Fungal | 2 | 1998 | 441 | 0.120 |
Why?
|
| Image Processing, Computer-Assisted | 8 | 2017 | 8928 | 0.120 |
Why?
|
| Treatment Failure | 4 | 2009 | 2659 | 0.120 |
Why?
|
| Acetophenones | 2 | 1992 | 52 | 0.120 |
Why?
|
| Mutagenesis | 4 | 1999 | 1228 | 0.120 |
Why?
|
| Ornithine Carbamoyltransferase | 2 | 1991 | 25 | 0.110 |
Why?
|
| HIV Seropositivity | 3 | 1995 | 962 | 0.110 |
Why?
|
| Feasibility Studies | 3 | 2021 | 5306 | 0.110 |
Why?
|
| Brain Diseases | 3 | 2014 | 1552 | 0.110 |
Why?
|
| Therapy, Computer-Assisted | 1 | 1996 | 265 | 0.110 |
Why?
|
| Protein Structure, Tertiary | 4 | 2010 | 3759 | 0.110 |
Why?
|
| History, 21st Century | 2 | 2017 | 1574 | 0.110 |
Why?
|
| Muramidase | 1 | 1994 | 163 | 0.110 |
Why?
|
| Neurologic Examination | 4 | 2007 | 913 | 0.110 |
Why?
|
| Cell Transdifferentiation | 1 | 2015 | 186 | 0.110 |
Why?
|
| Escherichia coli | 7 | 1997 | 4211 | 0.110 |
Why?
|
| Propylene Glycols | 1 | 2014 | 91 | 0.110 |
Why?
|
| Stomach | 6 | 1995 | 701 | 0.110 |
Why?
|
| Bone Marrow Transplantation | 2 | 1996 | 2730 | 0.110 |
Why?
|
| JC Virus | 1 | 2014 | 87 | 0.110 |
Why?
|
| Metalloendopeptidases | 1 | 1995 | 386 | 0.110 |
Why?
|
| Solubility | 2 | 2013 | 1078 | 0.110 |
Why?
|
| Retinal Detachment | 1 | 2018 | 429 | 0.110 |
Why?
|
| Microfilament Proteins | 2 | 2017 | 1130 | 0.110 |
Why?
|
| Mental Health | 4 | 2023 | 3269 | 0.110 |
Why?
|
| Chromatography, Ion Exchange | 1 | 2013 | 292 | 0.110 |
Why?
|
| Anti-Bacterial Agents | 3 | 2022 | 7475 | 0.110 |
Why?
|
| Hemagglutinins | 4 | 1982 | 111 | 0.110 |
Why?
|
| Hodgkin Disease | 1 | 2021 | 1384 | 0.110 |
Why?
|
| Cytotoxicity, Immunologic | 7 | 1996 | 1352 | 0.110 |
Why?
|
| Interleukin-1 | 3 | 1995 | 1251 | 0.110 |
Why?
|
| Blood Platelets | 2 | 2015 | 2465 | 0.110 |
Why?
|
| Eye Proteins | 3 | 1996 | 628 | 0.110 |
Why?
|
| Excitatory Amino Acid Transporter 1 | 1 | 2013 | 18 | 0.110 |
Why?
|
| Quantitative Trait Loci | 1 | 2021 | 2133 | 0.110 |
Why?
|
| Antibodies, Viral | 12 | 2022 | 3213 | 0.110 |
Why?
|
| Outpatients | 1 | 2021 | 1596 | 0.110 |
Why?
|
| Antilymphocyte Serum | 4 | 1984 | 492 | 0.110 |
Why?
|
| Topotecan | 1 | 2013 | 131 | 0.110 |
Why?
|
| Canada | 3 | 2022 | 2126 | 0.110 |
Why?
|
| Temporal Lobe | 4 | 2016 | 1716 | 0.110 |
Why?
|
| Chemokines, CXC | 4 | 2004 | 420 | 0.110 |
Why?
|
| Social Stigma | 1 | 2020 | 788 | 0.110 |
Why?
|
| Adrenergic beta-Agonists | 3 | 2010 | 345 | 0.100 |
Why?
|
| Sex Characteristics | 3 | 2019 | 2645 | 0.100 |
Why?
|
| Sigmoid Diseases | 1 | 1993 | 61 | 0.100 |
Why?
|
| Spinal Nerve Roots | 1 | 1993 | 122 | 0.100 |
Why?
|
| Amino Acids | 2 | 1997 | 1711 | 0.100 |
Why?
|
| Memory | 2 | 2016 | 2192 | 0.100 |
Why?
|
| Scavenger Receptors, Class A | 1 | 2013 | 52 | 0.100 |
Why?
|
| Glutamates | 1 | 1994 | 384 | 0.100 |
Why?
|
| Dementia | 3 | 1993 | 2741 | 0.100 |
Why?
|
| Databases, Factual | 6 | 2019 | 8065 | 0.100 |
Why?
|
| Contrast Media | 7 | 2016 | 5329 | 0.100 |
Why?
|
| Galactosyltransferases | 1 | 2014 | 283 | 0.100 |
Why?
|
| Embryo, Mammalian | 2 | 2013 | 1675 | 0.100 |
Why?
|
| Face | 1 | 2019 | 1029 | 0.100 |
Why?
|
| Lactococcus lactis | 1 | 2012 | 28 | 0.100 |
Why?
|
| Mass Spectrometry | 3 | 2020 | 2198 | 0.100 |
Why?
|
| Drug Substitution | 2 | 2017 | 292 | 0.100 |
Why?
|
| Statistics, Nonparametric | 4 | 2017 | 2846 | 0.100 |
Why?
|
| Sick Role | 2 | 1998 | 229 | 0.100 |
Why?
|
| Calcium-Binding Proteins | 1 | 2017 | 1080 | 0.100 |
Why?
|
| Mononuclear Phagocyte System | 1 | 2012 | 55 | 0.100 |
Why?
|
| Lipid Bilayers | 1 | 1994 | 376 | 0.100 |
Why?
|
| Electric Stimulation Therapy | 2 | 2012 | 635 | 0.100 |
Why?
|
| Mycobacterium leprae | 1 | 2012 | 95 | 0.100 |
Why?
|
| Genes, Bacterial | 1 | 2016 | 1076 | 0.100 |
Why?
|
| Mice, Inbred AKR | 3 | 2007 | 103 | 0.100 |
Why?
|
| Biological Evolution | 1 | 1998 | 1075 | 0.100 |
Why?
|
| Transcriptional Activation | 2 | 2016 | 1751 | 0.100 |
Why?
|
| Protein Isoforms | 3 | 2016 | 1716 | 0.100 |
Why?
|
| HLA-B Antigens | 2 | 2010 | 330 | 0.100 |
Why?
|
| Oligoclonal Bands | 1 | 2012 | 17 | 0.100 |
Why?
|
| Laminectomy | 1 | 1993 | 226 | 0.100 |
Why?
|
| Cross-Priming | 1 | 2012 | 75 | 0.100 |
Why?
|
| Societies, Medical | 1 | 2024 | 3957 | 0.100 |
Why?
|
| Diverticulum | 1 | 1993 | 137 | 0.100 |
Why?
|
| Excitatory Amino Acid Transporter 2 | 1 | 2013 | 88 | 0.100 |
Why?
|
| Serologic Tests | 1 | 2014 | 382 | 0.100 |
Why?
|
| Sphingosine | 1 | 2014 | 306 | 0.100 |
Why?
|
| Tissue Array Analysis | 1 | 2013 | 545 | 0.100 |
Why?
|
| Risk Factors | 15 | 2021 | 74889 | 0.100 |
Why?
|
| Postoperative Care | 1 | 2018 | 1480 | 0.100 |
Why?
|
| Craniopharyngioma | 1 | 1994 | 279 | 0.100 |
Why?
|
| Binding Sites, Antibody | 7 | 1999 | 340 | 0.100 |
Why?
|
| Membrane Microdomains | 1 | 2013 | 205 | 0.100 |
Why?
|
| Receptors, Interleukin-21 | 1 | 2011 | 32 | 0.100 |
Why?
|
| Models, Animal | 1 | 2018 | 2121 | 0.100 |
Why?
|
| Maternal Deprivation | 3 | 1988 | 40 | 0.100 |
Why?
|
| Neutrophils | 2 | 2024 | 3782 | 0.100 |
Why?
|
| Receptors, CCR | 1 | 2011 | 37 | 0.100 |
Why?
|
| Fas Ligand Protein | 1 | 2012 | 216 | 0.100 |
Why?
|
| Pancreas | 2 | 2010 | 1698 | 0.100 |
Why?
|
| Nerve Compression Syndromes | 1 | 1993 | 160 | 0.100 |
Why?
|
| Cerebellum | 3 | 2012 | 1520 | 0.100 |
Why?
|
| Hospitals, University | 1 | 2013 | 572 | 0.100 |
Why?
|
| Chromatography, Affinity | 1 | 1992 | 524 | 0.100 |
Why?
|
| Employment | 3 | 2015 | 1110 | 0.100 |
Why?
|
| Enzyme Induction | 1 | 2012 | 455 | 0.090 |
Why?
|
| Germinal Center | 2 | 2008 | 379 | 0.090 |
Why?
|
| Family Health | 1 | 1996 | 1254 | 0.090 |
Why?
|
| Syndrome | 3 | 2022 | 3271 | 0.090 |
Why?
|
| Functional Laterality | 4 | 2011 | 2244 | 0.090 |
Why?
|
| Restriction Mapping | 4 | 1995 | 848 | 0.090 |
Why?
|
| Caspase 1 | 1 | 2012 | 227 | 0.090 |
Why?
|
| Stress, Physiological | 3 | 1996 | 1407 | 0.090 |
Why?
|
| Aquaporin 4 | 1 | 2012 | 161 | 0.090 |
Why?
|
| Carcinoembryonic Antigen | 1 | 2012 | 338 | 0.090 |
Why?
|
| Intestinal Perforation | 1 | 1993 | 254 | 0.090 |
Why?
|
| Immunodominant Epitopes | 2 | 2006 | 244 | 0.090 |
Why?
|
| Interferon Regulatory Factors | 2 | 2010 | 272 | 0.090 |
Why?
|
| Dendritic Spines | 1 | 2013 | 244 | 0.090 |
Why?
|
| Image Enhancement | 4 | 2020 | 2858 | 0.090 |
Why?
|
| Islets of Langerhans | 3 | 1999 | 1350 | 0.090 |
Why?
|
| Transcription Factors | 4 | 2012 | 12159 | 0.090 |
Why?
|
| Gastrointestinal Motility | 5 | 1991 | 235 | 0.090 |
Why?
|
| Spinal Cord Compression | 1 | 1993 | 234 | 0.090 |
Why?
|
| Indoles | 2 | 2010 | 1834 | 0.090 |
Why?
|
| New York | 1 | 2013 | 879 | 0.090 |
Why?
|
| Hyperventilation | 1 | 1991 | 78 | 0.090 |
Why?
|
| Membrane Lipids | 1 | 2012 | 241 | 0.090 |
Why?
|
| Infarction, Middle Cerebral Artery | 2 | 2005 | 484 | 0.090 |
Why?
|
| Phagocytes | 1 | 2013 | 292 | 0.090 |
Why?
|
| Phosphoenolpyruvate Carboxykinase (GTP) | 1 | 2010 | 40 | 0.090 |
Why?
|
| Choroid Plexus Neoplasms | 1 | 2011 | 38 | 0.090 |
Why?
|
| Models, Chemical | 3 | 1999 | 607 | 0.090 |
Why?
|
| Hedgehog Proteins | 3 | 2005 | 771 | 0.090 |
Why?
|
| Genetic Association Studies | 1 | 2020 | 2744 | 0.090 |
Why?
|
| Oncogene Protein v-maf | 1 | 2010 | 5 | 0.090 |
Why?
|
| Drug Administration Schedule | 4 | 2010 | 4853 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 12 | 2016 | 10745 | 0.090 |
Why?
|
| Smad2 Protein | 1 | 2011 | 144 | 0.090 |
Why?
|
| HLA Antigens | 4 | 2010 | 1339 | 0.090 |
Why?
|
| Antirheumatic Agents | 1 | 2020 | 1383 | 0.090 |
Why?
|
| Phospholipids | 1 | 1994 | 778 | 0.090 |
Why?
|
| Immunoglobulin Idiotypes | 4 | 1986 | 200 | 0.090 |
Why?
|
| Alleles | 10 | 2022 | 6896 | 0.090 |
Why?
|
| Food Hypersensitivity | 1 | 2018 | 734 | 0.090 |
Why?
|
| Nerve Degeneration | 3 | 2017 | 748 | 0.090 |
Why?
|
| Blood Platelet Disorders | 1 | 2011 | 60 | 0.090 |
Why?
|
| Medulla Oblongata | 2 | 2008 | 247 | 0.090 |
Why?
|
| Macromolecular Substances | 5 | 1997 | 1431 | 0.090 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2022 | 1882 | 0.090 |
Why?
|
| Practice Guidelines as Topic | 3 | 2021 | 7430 | 0.090 |
Why?
|
| Mycophenolic Acid | 1 | 2013 | 349 | 0.090 |
Why?
|
| Aspartic Acid | 1 | 2013 | 575 | 0.090 |
Why?
|
| Cerebral Ventricles | 2 | 2012 | 550 | 0.090 |
Why?
|
| Infusions, Intravenous | 6 | 2012 | 2228 | 0.090 |
Why?
|
| Genes, Reporter | 2 | 2012 | 1525 | 0.090 |
Why?
|
| Leptin | 2 | 2021 | 1596 | 0.090 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2000 | 1836 | 0.090 |
Why?
|
| Furin | 1 | 2010 | 45 | 0.090 |
Why?
|
| TNF Receptor-Associated Factor 3 | 1 | 2010 | 38 | 0.090 |
Why?
|
| Disease Susceptibility | 6 | 2021 | 1791 | 0.090 |
Why?
|
| Neuroimmunomodulation | 2 | 2006 | 186 | 0.090 |
Why?
|
| Brain Ischemia | 1 | 2003 | 3001 | 0.090 |
Why?
|
| RNA, Untranslated | 1 | 2014 | 455 | 0.090 |
Why?
|
| Recombination, Genetic | 8 | 2010 | 1524 | 0.090 |
Why?
|
| Genes, MHC Class II | 4 | 2005 | 433 | 0.090 |
Why?
|
| Cell Count | 4 | 2004 | 1826 | 0.090 |
Why?
|
| Intracellular Fluid | 1 | 2010 | 201 | 0.090 |
Why?
|
| Protein Binding | 6 | 2024 | 9326 | 0.090 |
Why?
|
| Cholesterol | 2 | 2010 | 2904 | 0.090 |
Why?
|
| Molecular Structure | 3 | 2008 | 1882 | 0.090 |
Why?
|
| Emulsions | 1 | 2010 | 150 | 0.090 |
Why?
|
| Europe | 3 | 2016 | 3430 | 0.090 |
Why?
|
| Glucocorticoids | 1 | 1999 | 2158 | 0.090 |
Why?
|
| Double-Blind Method | 12 | 2016 | 12430 | 0.090 |
Why?
|
| Head and Neck Neoplasms | 2 | 2019 | 2930 | 0.090 |
Why?
|
| Gene Deletion | 3 | 2004 | 2669 | 0.090 |
Why?
|
| Sequence Analysis, RNA | 1 | 2018 | 2039 | 0.090 |
Why?
|
| Blood Coagulation Tests | 1 | 2011 | 269 | 0.090 |
Why?
|
| Gadolinium DTPA | 3 | 2007 | 823 | 0.090 |
Why?
|
| Verbal Behavior | 1 | 2011 | 328 | 0.090 |
Why?
|
| Cervical Vertebrae | 2 | 1993 | 978 | 0.080 |
Why?
|
| T-Box Domain Proteins | 1 | 2012 | 471 | 0.080 |
Why?
|
| Gender Identity | 1 | 1996 | 767 | 0.080 |
Why?
|
| Proteome | 1 | 2020 | 1894 | 0.080 |
Why?
|
| Macrophages, Alveolar | 1 | 2012 | 413 | 0.080 |
Why?
|
| Tetanus Toxoid | 4 | 2004 | 188 | 0.080 |
Why?
|
| Hydroxycholesterols | 1 | 2009 | 23 | 0.080 |
Why?
|
| Haplotypes | 4 | 2022 | 2726 | 0.080 |
Why?
|
| Glucosylceramides | 1 | 2009 | 27 | 0.080 |
Why?
|
| Adjuvants, Pharmaceutic | 1 | 2009 | 48 | 0.080 |
Why?
|
| Suction | 1 | 2011 | 268 | 0.080 |
Why?
|
| Anticonvulsants | 3 | 2011 | 1921 | 0.080 |
Why?
|
| Epidemiologic Research Design | 1 | 2013 | 368 | 0.080 |
Why?
|
| Neutralization Tests | 2 | 2011 | 736 | 0.080 |
Why?
|
| Cell Migration Inhibition | 1 | 2009 | 97 | 0.080 |
Why?
|
| Receptors, Interferon | 1 | 2009 | 115 | 0.080 |
Why?
|
| C-Reactive Protein | 1 | 2021 | 3853 | 0.080 |
Why?
|
| Glutamine | 3 | 2013 | 575 | 0.080 |
Why?
|
| Nerve Tissue Proteins | 4 | 2014 | 4401 | 0.080 |
Why?
|
| Efficiency | 1 | 2012 | 479 | 0.080 |
Why?
|
| Chemotaxis | 1 | 2012 | 598 | 0.080 |
Why?
|
| Injections, Intraperitoneal | 3 | 1999 | 411 | 0.080 |
Why?
|
| Mice, Obese | 1 | 2010 | 417 | 0.080 |
Why?
|
| Anatomy, Cross-Sectional | 1 | 2009 | 139 | 0.080 |
Why?
|
| Acute Disease | 8 | 2007 | 7240 | 0.080 |
Why?
|
| Cross Reactions | 4 | 2002 | 826 | 0.080 |
Why?
|
| Circular Dichroism | 3 | 2000 | 333 | 0.080 |
Why?
|
| Alcohol Drinking | 4 | 2017 | 4045 | 0.080 |
Why?
|
| Crosses, Genetic | 4 | 2001 | 751 | 0.080 |
Why?
|
| Visual Acuity | 2 | 2021 | 2714 | 0.080 |
Why?
|
| Serotonin | 6 | 2015 | 1045 | 0.080 |
Why?
|
| Memory Disorders | 1 | 2016 | 1193 | 0.080 |
Why?
|
| Statistics as Topic | 4 | 2011 | 2350 | 0.080 |
Why?
|
| Genes, Viral | 4 | 1980 | 654 | 0.080 |
Why?
|
| Glioblastoma | 3 | 2019 | 3458 | 0.080 |
Why?
|
| Integrin alphaV | 1 | 2008 | 54 | 0.080 |
Why?
|
| Latent TGF-beta Binding Proteins | 1 | 2008 | 45 | 0.080 |
Why?
|
| Jurkat Cells | 1 | 2010 | 740 | 0.080 |
Why?
|
| Cranial Nerve Diseases | 1 | 2009 | 111 | 0.080 |
Why?
|
| Facial Paralysis | 1 | 1993 | 346 | 0.080 |
Why?
|
| DNA Primers | 4 | 2004 | 2826 | 0.080 |
Why?
|
| Cyanamide | 2 | 1985 | 3 | 0.080 |
Why?
|
| Receptors, Interleukin-15 | 1 | 2008 | 13 | 0.080 |
Why?
|
| Phylogeny | 1 | 2016 | 2840 | 0.080 |
Why?
|
| Fullerenes | 1 | 2008 | 14 | 0.080 |
Why?
|
| Radiopharmaceuticals | 1 | 2018 | 2703 | 0.080 |
Why?
|
| Genetic Vectors | 2 | 2011 | 3401 | 0.080 |
Why?
|
| Congresses as Topic | 1 | 2013 | 811 | 0.080 |
Why?
|
| Neurology | 1 | 2016 | 785 | 0.080 |
Why?
|
| Parkinson Disease | 1 | 2022 | 2884 | 0.080 |
Why?
|
| Integrin beta3 | 1 | 2008 | 120 | 0.080 |
Why?
|
| Amino Acid Transport System X-AG | 1 | 2008 | 38 | 0.080 |
Why?
|
| Blood Proteins | 2 | 2024 | 1194 | 0.080 |
Why?
|
| Disulfiram | 2 | 1985 | 63 | 0.080 |
Why?
|
| Comorbidity | 3 | 2020 | 10580 | 0.070 |
Why?
|
| Models, Neurological | 4 | 2010 | 1747 | 0.070 |
Why?
|
| Paresis | 1 | 2009 | 177 | 0.070 |
Why?
|
| Lactosylceramides | 2 | 2020 | 15 | 0.070 |
Why?
|
| Combined Modality Therapy | 8 | 2010 | 8540 | 0.070 |
Why?
|
| Medical Records | 1 | 2013 | 1408 | 0.070 |
Why?
|
| Subtraction Technique | 1 | 2011 | 514 | 0.070 |
Why?
|
| Blotting, Western | 7 | 2011 | 5022 | 0.070 |
Why?
|
| Platelet Aggregation | 1 | 2011 | 769 | 0.070 |
Why?
|
| Genes | 2 | 1990 | 1824 | 0.070 |
Why?
|
| Thymectomy | 4 | 2001 | 200 | 0.070 |
Why?
|
| Vancomycin | 2 | 2022 | 504 | 0.070 |
Why?
|
| Blood Coagulation Disorders | 1 | 2011 | 350 | 0.070 |
Why?
|
| Poliovirus Vaccine, Inactivated | 1 | 1987 | 24 | 0.070 |
Why?
|
| Anti-Inflammatory Agents | 1 | 1997 | 1805 | 0.070 |
Why?
|
| Anxiety | 3 | 2020 | 4668 | 0.070 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2012 | 800 | 0.070 |
Why?
|
| Thiazoles | 2 | 2016 | 1529 | 0.070 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 4 | 2018 | 11876 | 0.070 |
Why?
|
| Receptors, IgG | 1 | 2011 | 562 | 0.070 |
Why?
|
| Organ Size | 3 | 2017 | 2262 | 0.070 |
Why?
|
| Nerve Net | 1 | 2020 | 2307 | 0.070 |
Why?
|
| Tretinoin | 1 | 2010 | 524 | 0.070 |
Why?
|
| Algorithms | 6 | 2023 | 14073 | 0.070 |
Why?
|
| Medical Oncology | 1 | 1999 | 2340 | 0.070 |
Why?
|
| Promoter Regions, Genetic | 3 | 2010 | 5795 | 0.070 |
Why?
|
| Arnold-Chiari Malformation | 1 | 2009 | 159 | 0.070 |
Why?
|
| Cognition | 7 | 2020 | 7057 | 0.070 |
Why?
|
| Neurilemmoma | 1 | 1993 | 522 | 0.070 |
Why?
|
| Arrestin | 4 | 1997 | 30 | 0.070 |
Why?
|
| Amino Acid Substitution | 2 | 2003 | 1742 | 0.070 |
Why?
|
| Lipid Metabolism | 1 | 1996 | 1895 | 0.070 |
Why?
|
| Enzyme Activation | 7 | 2000 | 3587 | 0.070 |
Why?
|
| Transduction, Genetic | 1 | 2010 | 899 | 0.070 |
Why?
|
| Lentivirus | 1 | 2010 | 518 | 0.070 |
Why?
|
| Cross-Sectional Studies | 8 | 2025 | 26309 | 0.070 |
Why?
|
| Single Person | 1 | 1987 | 31 | 0.070 |
Why?
|
| DNA Methylation | 1 | 2021 | 4427 | 0.070 |
Why?
|
| Proteins | 4 | 2003 | 6002 | 0.070 |
Why?
|
| Glycosylation | 1 | 2010 | 1099 | 0.070 |
Why?
|
| Anorexia Nervosa | 3 | 1989 | 1328 | 0.070 |
Why?
|
| Artifacts | 1 | 2016 | 1897 | 0.070 |
Why?
|
| Gene Regulatory Networks | 2 | 2014 | 1752 | 0.070 |
Why?
|
| T-Lymphocytes, Cytotoxic | 7 | 2015 | 1802 | 0.070 |
Why?
|
| Adrenal Cortex Hormones | 3 | 1993 | 1884 | 0.070 |
Why?
|
| Streptozocin | 1 | 2007 | 189 | 0.070 |
Why?
|
| Chromosome Mapping | 7 | 2009 | 4618 | 0.070 |
Why?
|
| Magnetoencephalography | 1 | 2011 | 585 | 0.070 |
Why?
|
| HeLa Cells | 7 | 1999 | 3073 | 0.070 |
Why?
|
| Guidelines as Topic | 1 | 2013 | 1394 | 0.070 |
Why?
|
| Forecasting | 3 | 2007 | 2936 | 0.070 |
Why?
|
| Hyperplasia | 1 | 2010 | 1150 | 0.070 |
Why?
|
| Feedback, Physiological | 1 | 2009 | 481 | 0.070 |
Why?
|
| Chemokine CXCL10 | 5 | 2013 | 311 | 0.070 |
Why?
|
| Lymphocyte Count | 3 | 2017 | 794 | 0.070 |
Why?
|
| Synaptosomes | 1 | 1987 | 116 | 0.070 |
Why?
|
| Growth Substances | 1 | 1989 | 759 | 0.070 |
Why?
|
| Natural Killer T-Cells | 1 | 2010 | 319 | 0.070 |
Why?
|
| Ribonuclease, Pancreatic | 1 | 1987 | 112 | 0.070 |
Why?
|
| Nanotechnology | 1 | 2012 | 702 | 0.070 |
Why?
|
| Paraplegia | 1 | 2007 | 161 | 0.070 |
Why?
|
| Lectins, C-Type | 1 | 2010 | 592 | 0.070 |
Why?
|
| Interleukin-23 Subunit p19 | 1 | 2006 | 23 | 0.070 |
Why?
|
| Interleukin-12 Subunit p35 | 1 | 2006 | 22 | 0.070 |
Why?
|
| Dipeptidyl Peptidase 4 | 2 | 2000 | 93 | 0.070 |
Why?
|
| Genes, Lethal | 1 | 2007 | 224 | 0.070 |
Why?
|
| Carbazoles | 1 | 2008 | 230 | 0.070 |
Why?
|
| Subacute Sclerosing Panencephalitis | 3 | 1988 | 26 | 0.070 |
Why?
|
| Acetyl-CoA C-Acyltransferase | 2 | 1996 | 23 | 0.070 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2011 | 4047 | 0.070 |
Why?
|
| Interleukin-1beta | 1 | 2012 | 1026 | 0.070 |
Why?
|
| Immunogenetics | 1 | 2006 | 62 | 0.070 |
Why?
|
| Defense Mechanisms | 3 | 1994 | 178 | 0.070 |
Why?
|
| Monitoring, Intraoperative | 2 | 2004 | 947 | 0.060 |
Why?
|
| Integrin alpha4 | 1 | 2006 | 89 | 0.060 |
Why?
|
| Myocardium | 2 | 2009 | 4765 | 0.060 |
Why?
|
| Fishes | 1 | 1989 | 607 | 0.060 |
Why?
|
| Stroke | 2 | 2005 | 9744 | 0.060 |
Why?
|
| Health Personnel | 1 | 2020 | 3384 | 0.060 |
Why?
|
| Pituitary Neoplasms | 1 | 1994 | 1324 | 0.060 |
Why?
|
| Nuclear Proteins | 1 | 2000 | 5795 | 0.060 |
Why?
|
| Intestinal Absorption | 1 | 2007 | 400 | 0.060 |
Why?
|
| Hypergammaglobulinemia | 1 | 1986 | 71 | 0.060 |
Why?
|
| Goats | 2 | 2003 | 166 | 0.060 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2011 | 1143 | 0.060 |
Why?
|
| Esterases | 2 | 1987 | 89 | 0.060 |
Why?
|
| Gene Frequency | 4 | 2022 | 3624 | 0.060 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 1993 | 1023 | 0.060 |
Why?
|
| Lumbosacral Region | 1 | 2007 | 294 | 0.060 |
Why?
|
| Incidence | 6 | 2024 | 21527 | 0.060 |
Why?
|
| Models, Molecular | 4 | 2000 | 5388 | 0.060 |
Why?
|
| Signal Processing, Computer-Assisted | 3 | 2002 | 1457 | 0.060 |
Why?
|
| Receptor, Bradykinin B1 | 1 | 2005 | 12 | 0.060 |
Why?
|
| Cell Separation | 6 | 1990 | 1718 | 0.060 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 1995 | 2841 | 0.060 |
Why?
|
| Hydrogen-Ion Concentration | 3 | 2000 | 2478 | 0.060 |
Why?
|
| Antigens, Bacterial | 2 | 2002 | 1148 | 0.060 |
Why?
|
| Mice, Congenic | 3 | 1999 | 98 | 0.060 |
Why?
|
| Immunoglobulin A | 3 | 2012 | 992 | 0.060 |
Why?
|
| Mutation | 4 | 2018 | 30214 | 0.060 |
Why?
|
| Nitrates | 1 | 2007 | 259 | 0.060 |
Why?
|
| Gastric Mucosa | 3 | 1996 | 602 | 0.060 |
Why?
|
| Equipment Failure | 3 | 2010 | 585 | 0.060 |
Why?
|
| Chemotaxis, Leukocyte | 3 | 2018 | 661 | 0.060 |
Why?
|
| Benzaldehydes | 1 | 1985 | 59 | 0.060 |
Why?
|
| Drug Administration Routes | 1 | 2005 | 152 | 0.060 |
Why?
|
| Pyrrolidonecarboxylic Acid | 9 | 1995 | 66 | 0.060 |
Why?
|
| Drug Monitoring | 1 | 2011 | 962 | 0.060 |
Why?
|
| Catalysis | 3 | 1995 | 767 | 0.060 |
Why?
|
| Hospitals | 1 | 2018 | 3885 | 0.060 |
Why?
|
| Peptide Hydrolases | 1 | 1988 | 610 | 0.060 |
Why?
|
| Apoproteins | 3 | 2001 | 45 | 0.060 |
Why?
|
| Lung | 2 | 2021 | 10068 | 0.060 |
Why?
|
| H-2 Antigens | 4 | 2001 | 359 | 0.060 |
Why?
|
| Immunologic Capping | 2 | 1981 | 30 | 0.060 |
Why?
|
| Complementarity Determining Regions | 2 | 2021 | 154 | 0.060 |
Why?
|
| Patient Satisfaction | 1 | 2017 | 3485 | 0.060 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2005 | 1168 | 0.060 |
Why?
|
| Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 3 | 1995 | 94 | 0.060 |
Why?
|
| Gene Silencing | 1 | 2011 | 1505 | 0.060 |
Why?
|
| Psychiatric Status Rating Scales | 6 | 1997 | 6020 | 0.060 |
Why?
|
| Infant, Newborn | 5 | 2024 | 26387 | 0.060 |
Why?
|
| Fibroblast Growth Factors | 2 | 1999 | 871 | 0.060 |
Why?
|
| Antibody Specificity | 6 | 1998 | 1062 | 0.060 |
Why?
|
| Memory, Short-Term | 1 | 2011 | 1004 | 0.060 |
Why?
|
| Cyanides | 1 | 1985 | 82 | 0.060 |
Why?
|
| Drug Tolerance | 2 | 2001 | 365 | 0.060 |
Why?
|
| Foreign-Body Migration | 2 | 2005 | 220 | 0.060 |
Why?
|
| Gastric Emptying | 1 | 1987 | 247 | 0.060 |
Why?
|
| Ovary | 1 | 1989 | 963 | 0.060 |
Why?
|
| Dopamine | 4 | 1980 | 1581 | 0.060 |
Why?
|
| Belgium | 2 | 2014 | 119 | 0.060 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 4 | 1997 | 812 | 0.060 |
Why?
|
| South America | 1 | 2004 | 180 | 0.060 |
Why?
|
| Radiography | 4 | 2014 | 6968 | 0.060 |
Why?
|
| Pinealoma | 1 | 2024 | 52 | 0.060 |
Why?
|
| Sepsis | 1 | 2018 | 2604 | 0.060 |
Why?
|
| Chronic Disease | 7 | 2008 | 9358 | 0.060 |
Why?
|
| Factor VIII | 1 | 2006 | 349 | 0.060 |
Why?
|
| Craniofacial Dysostosis | 1 | 2004 | 74 | 0.060 |
Why?
|
| Regression Analysis | 4 | 2001 | 6329 | 0.060 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2018 | 2429 | 0.060 |
Why?
|
| Intelligence | 2 | 2016 | 925 | 0.060 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 1990 | 713 | 0.060 |
Why?
|
| Antibody-Dependent Cell Cytotoxicity | 3 | 1981 | 306 | 0.060 |
Why?
|
| Spectrometry, Fluorescence | 3 | 1996 | 694 | 0.050 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2013 | 3610 | 0.050 |
Why?
|
| Intracranial Aneurysm | 1 | 1993 | 1271 | 0.050 |
Why?
|
| Aged, 80 and over | 10 | 2020 | 59548 | 0.050 |
Why?
|
| Research Design | 8 | 2021 | 6206 | 0.050 |
Why?
|
| Fetal Blood | 1 | 2010 | 1367 | 0.050 |
Why?
|
| Receptors, Antigen, B-Cell | 5 | 1982 | 546 | 0.050 |
Why?
|
| Markov Chains | 1 | 2007 | 974 | 0.050 |
Why?
|
| Neural Pathways | 2 | 2007 | 3079 | 0.050 |
Why?
|
| Fluorescent Antibody Technique | 9 | 1995 | 2470 | 0.050 |
Why?
|
| Cerebral Amyloid Angiopathy | 1 | 2011 | 887 | 0.050 |
Why?
|
| Serum Albumin, Bovine | 3 | 1995 | 319 | 0.050 |
Why?
|
| Anti-Glomerular Basement Membrane Disease | 1 | 2003 | 41 | 0.050 |
Why?
|
| Leukopenia | 2 | 2017 | 213 | 0.050 |
Why?
|
| Cysteine | 3 | 1995 | 896 | 0.050 |
Why?
|
| Retroviridae | 2 | 2002 | 846 | 0.050 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 1987 | 549 | 0.050 |
Why?
|
| Compulsive Behavior | 1 | 2024 | 117 | 0.050 |
Why?
|
| Testosterone | 1 | 2014 | 2495 | 0.050 |
Why?
|
| Serine | 2 | 1999 | 828 | 0.050 |
Why?
|
| Homosexuality | 2 | 1994 | 268 | 0.050 |
Why?
|
| Cricetinae | 2 | 2006 | 2416 | 0.050 |
Why?
|
| Receptors, Cytokine | 1 | 2004 | 258 | 0.050 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 2003 | 167 | 0.050 |
Why?
|
| Alcoholism | 2 | 1991 | 1980 | 0.050 |
Why?
|
| Genetic Linkage | 5 | 2001 | 2342 | 0.050 |
Why?
|
| Texas | 1 | 2024 | 410 | 0.050 |
Why?
|
| Preoperative Care | 2 | 2009 | 2253 | 0.050 |
Why?
|
| Mucous Membrane | 1 | 2006 | 659 | 0.050 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2005 | 461 | 0.050 |
Why?
|
| Age Factors | 7 | 2015 | 18397 | 0.050 |
Why?
|
| Macrophage Inflammatory Proteins | 2 | 2000 | 121 | 0.050 |
Why?
|
| Body Mass Index | 3 | 2021 | 13050 | 0.050 |
Why?
|
| Logistic Models | 5 | 2021 | 13276 | 0.050 |
Why?
|
| United States | 10 | 2024 | 72945 | 0.050 |
Why?
|
| Protein Subunits | 1 | 2006 | 940 | 0.050 |
Why?
|
| Biotinylation | 1 | 2003 | 184 | 0.050 |
Why?
|
| Viral Proteins | 4 | 2003 | 1801 | 0.050 |
Why?
|
| Allergens | 1 | 2010 | 1436 | 0.050 |
Why?
|
| Receptors, Interleukin-18 | 1 | 2002 | 25 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3110 | 0.050 |
Why?
|
| Interleukin-18 Receptor alpha Subunit | 1 | 2002 | 18 | 0.050 |
Why?
|
| Epitope Mapping | 1 | 2003 | 301 | 0.050 |
Why?
|
| Mice, Inbred A | 5 | 2006 | 245 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3232 | 0.050 |
Why?
|
| Biopsy | 5 | 2015 | 6779 | 0.050 |
Why?
|
| Disease-Free Survival | 5 | 2014 | 6853 | 0.050 |
Why?
|
| Extracellular Matrix | 2 | 1991 | 1730 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 5 | 2006 | 10384 | 0.050 |
Why?
|
| Neoplasms, Second Primary | 1 | 2010 | 1062 | 0.050 |
Why?
|
| Chloral Hydrate | 1 | 1982 | 28 | 0.050 |
Why?
|
| Neoplasm, Residual | 2 | 1999 | 1012 | 0.050 |
Why?
|
| Cholesterol, Dietary | 1 | 2002 | 224 | 0.050 |
Why?
|
| Animal Nutritional Physiological Phenomena | 2 | 1978 | 54 | 0.050 |
Why?
|
| Tomography, Emission-Computed | 2 | 1997 | 1006 | 0.050 |
Why?
|
| Pepsinogens | 2 | 1991 | 7 | 0.050 |
Why?
|
| X-Ray Diffraction | 2 | 1993 | 414 | 0.050 |
Why?
|
| Bone Marrow Cells | 3 | 2008 | 2413 | 0.050 |
Why?
|
| Basal Ganglia | 2 | 1997 | 549 | 0.050 |
Why?
|
| Wakefulness | 1 | 2009 | 1282 | 0.050 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2016 | 3230 | 0.050 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2018 | 3633 | 0.050 |
Why?
|
| Neuronavigation | 2 | 2015 | 169 | 0.050 |
Why?
|
| Cell Physiological Phenomena | 1 | 2023 | 149 | 0.050 |
Why?
|
| Chi-Square Distribution | 3 | 2010 | 3431 | 0.050 |
Why?
|
| Intubation, Gastrointestinal | 1 | 2003 | 166 | 0.050 |
Why?
|
| Parietal Lobe | 3 | 2002 | 860 | 0.050 |
Why?
|
| Butyrates | 1 | 2022 | 164 | 0.050 |
Why?
|
| Crystallization | 2 | 1993 | 518 | 0.050 |
Why?
|
| Gestational Age | 2 | 2024 | 3617 | 0.050 |
Why?
|
| Antigens, Viral | 3 | 1987 | 995 | 0.050 |
Why?
|
| Dextran Sulfate | 2 | 2018 | 256 | 0.050 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2005 | 633 | 0.050 |
Why?
|
| Heparin | 1 | 1989 | 1636 | 0.050 |
Why?
|
| Cerebral Aqueduct | 1 | 2001 | 39 | 0.050 |
Why?
|
| Antigens, CD20 | 1 | 2022 | 199 | 0.050 |
Why?
|
| Tetrahydroisoquinolines | 1 | 1982 | 81 | 0.050 |
Why?
|
| Inappropriate ADH Syndrome | 1 | 2001 | 59 | 0.050 |
Why?
|
| Nerve Regeneration | 1 | 2007 | 796 | 0.050 |
Why?
|
| Autistic Disorder | 1 | 2011 | 1238 | 0.050 |
Why?
|
| Delirium | 1 | 1993 | 1698 | 0.050 |
Why?
|
| Blood Transfusion, Autologous | 1 | 2002 | 130 | 0.050 |
Why?
|
| Pregnancy Proteins | 1 | 2002 | 222 | 0.050 |
Why?
|
| Cell Line, Tumor | 3 | 2019 | 17089 | 0.050 |
Why?
|
| Evoked Potentials, Auditory | 1 | 2024 | 529 | 0.050 |
Why?
|
| Electronic Health Records | 2 | 2021 | 4880 | 0.050 |
Why?
|
| Interpersonal Relations | 1 | 1989 | 1432 | 0.050 |
Why?
|
| Pituitary Hormones, Anterior | 1 | 1981 | 57 | 0.050 |
Why?
|
| Adrenergic beta-2 Receptor Agonists | 1 | 2002 | 109 | 0.050 |
Why?
|
| Cell Survival | 4 | 2018 | 5749 | 0.050 |
Why?
|
| Muscle Cramp | 1 | 1980 | 33 | 0.050 |
Why?
|
| T-Cell Antigen Receptor Specificity | 1 | 2021 | 89 | 0.050 |
Why?
|
| Lymph | 1 | 2001 | 78 | 0.050 |
Why?
|
| Immunoglobulins | 4 | 1986 | 853 | 0.050 |
Why?
|
| Kaplan-Meier Estimate | 4 | 2014 | 6514 | 0.050 |
Why?
|
| Mycobacterium | 1 | 2002 | 252 | 0.050 |
Why?
|
| Receptors, Interleukin | 1 | 2002 | 243 | 0.050 |
Why?
|
| Breast Implants | 1 | 2005 | 414 | 0.050 |
Why?
|
| Cell Lineage | 1 | 2010 | 2573 | 0.050 |
Why?
|
| Diagnosis, Differential | 6 | 1999 | 12985 | 0.040 |
Why?
|
| PubMed | 1 | 2021 | 129 | 0.040 |
Why?
|
| Ketones | 1 | 1982 | 183 | 0.040 |
Why?
|
| Thoracic Duct | 1 | 2001 | 71 | 0.040 |
Why?
|
| Internet | 1 | 2013 | 3113 | 0.040 |
Why?
|
| Agglutinins | 1 | 1980 | 28 | 0.040 |
Why?
|
| In Situ Hybridization | 3 | 2012 | 1892 | 0.040 |
Why?
|
| Research Subjects | 1 | 2022 | 248 | 0.040 |
Why?
|
| Mycobacterium tuberculosis | 3 | 1999 | 1911 | 0.040 |
Why?
|
| Nanoparticles | 1 | 2012 | 1966 | 0.040 |
Why?
|
| Receptors, CCR5 | 2 | 2000 | 491 | 0.040 |
Why?
|
| Job Satisfaction | 1 | 2024 | 548 | 0.040 |
Why?
|
| Binding, Competitive | 3 | 1988 | 1141 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 6 | 2023 | 20710 | 0.040 |
Why?
|
| Administration, Cutaneous | 2 | 2012 | 712 | 0.040 |
Why?
|
| Knowledge | 1 | 2022 | 178 | 0.040 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2005 | 627 | 0.040 |
Why?
|
| Isoquinolines | 1 | 1982 | 349 | 0.040 |
Why?
|
| Dacarbazine | 1 | 2003 | 552 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 2 | 2015 | 1604 | 0.040 |
Why?
|
| Hydroxybutyrates | 1 | 2020 | 76 | 0.040 |
Why?
|
| Pregnancy | 6 | 2024 | 30236 | 0.040 |
Why?
|
| Iron | 1 | 2009 | 1812 | 0.040 |
Why?
|
| British Columbia | 1 | 2020 | 239 | 0.040 |
Why?
|
| Acoustic Stimulation | 1 | 2024 | 1253 | 0.040 |
Why?
|
| Alcohol Oxidoreductases | 3 | 1977 | 164 | 0.040 |
Why?
|
| Optic Nerve Injuries | 1 | 2001 | 150 | 0.040 |
Why?
|
| Transfection | 2 | 2006 | 5755 | 0.040 |
Why?
|
| Phosphorylation | 1 | 2011 | 8310 | 0.040 |
Why?
|
| Electron Transport | 2 | 1995 | 211 | 0.040 |
Why?
|
| Staining and Labeling | 3 | 2003 | 1075 | 0.040 |
Why?
|
| Microsomes, Liver | 2 | 2012 | 174 | 0.040 |
Why?
|
| Public Opinion | 1 | 2023 | 484 | 0.040 |
Why?
|
| Surgical Flaps | 1 | 2008 | 1680 | 0.040 |
Why?
|
| Gait | 2 | 1995 | 823 | 0.040 |
Why?
|
| Focal Adhesion Kinase 1 | 1 | 2000 | 120 | 0.040 |
Why?
|
| Health Surveys | 1 | 2009 | 4055 | 0.040 |
Why?
|
| Codon | 2 | 1993 | 599 | 0.040 |
Why?
|
| Heart Rate | 1 | 1991 | 4207 | 0.040 |
Why?
|
| Transcription, Genetic | 5 | 1997 | 7612 | 0.040 |
Why?
|
| Dependovirus | 1 | 2004 | 720 | 0.040 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2015 | 4050 | 0.040 |
Why?
|
| Neuritis, Autoimmune, Experimental | 2 | 1989 | 5 | 0.040 |
Why?
|
| Carcinoma | 1 | 2011 | 2325 | 0.040 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2000 | 183 | 0.040 |
Why?
|
| Self Report | 1 | 2011 | 3771 | 0.040 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2003 | 614 | 0.040 |
Why?
|
| Genomics | 2 | 2021 | 5922 | 0.040 |
Why?
|
| Heart Transplantation | 3 | 2008 | 3306 | 0.040 |
Why?
|
| Aminosalicylic Acid | 1 | 2018 | 20 | 0.040 |
Why?
|
| Survival Analysis | 3 | 2013 | 10101 | 0.040 |
Why?
|
| Blood Glucose | 2 | 2010 | 6422 | 0.040 |
Why?
|
| Nausea | 1 | 2002 | 681 | 0.040 |
Why?
|
| Hyponatremia | 1 | 2001 | 278 | 0.040 |
Why?
|
| Dimerization | 1 | 2000 | 882 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 3 | 2001 | 6105 | 0.040 |
Why?
|
| Tachycardia | 2 | 1991 | 598 | 0.040 |
Why?
|
| Software | 1 | 2013 | 4464 | 0.040 |
Why?
|
| Immunoenzyme Techniques | 3 | 1988 | 1697 | 0.040 |
Why?
|
| Behavior, Animal | 2 | 2005 | 1865 | 0.040 |
Why?
|
| Corpus Callosum | 1 | 2023 | 751 | 0.040 |
Why?
|
| Hospitalization | 3 | 2016 | 10816 | 0.040 |
Why?
|
| Colorectal Neoplasms | 1 | 2018 | 6965 | 0.040 |
Why?
|
| Coenzymes | 1 | 1999 | 101 | 0.040 |
Why?
|
| Thalamus | 2 | 1997 | 1040 | 0.040 |
Why?
|
| Smoking | 3 | 2011 | 9077 | 0.040 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2004 | 1657 | 0.040 |
Why?
|
| Health Status | 2 | 2009 | 4087 | 0.040 |
Why?
|
| Zebrafish | 1 | 2010 | 3035 | 0.040 |
Why?
|
| Cluster Analysis | 2 | 2017 | 2721 | 0.040 |
Why?
|
| Antigens, Helminth | 1 | 1998 | 69 | 0.040 |
Why?
|
| Remission Induction | 2 | 2018 | 2413 | 0.040 |
Why?
|
| Superior Sagittal Sinus | 1 | 2017 | 15 | 0.040 |
Why?
|
| Threonine | 1 | 1999 | 272 | 0.040 |
Why?
|
| Peptide Chain Initiation, Translational | 1 | 1998 | 100 | 0.040 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 1989 | 1057 | 0.040 |
Why?
|
| Remission, Spontaneous | 2 | 1998 | 384 | 0.040 |
Why?
|
| Secondary Prevention | 1 | 2004 | 1469 | 0.040 |
Why?
|
| Viruses | 1 | 1982 | 371 | 0.040 |
Why?
|
| Measles | 2 | 1979 | 180 | 0.040 |
Why?
|
| Intraoperative Care | 1 | 2002 | 768 | 0.040 |
Why?
|
| Emotions | 2 | 2024 | 2758 | 0.040 |
Why?
|
| Joints | 1 | 1999 | 324 | 0.040 |
Why?
|
| Demography | 2 | 2013 | 1641 | 0.040 |
Why?
|
| Cations, Divalent | 1 | 1998 | 167 | 0.040 |
Why?
|
| Behavior | 1 | 1981 | 538 | 0.040 |
Why?
|
| Selection Bias | 1 | 1999 | 359 | 0.040 |
Why?
|
| Locomotion | 2 | 1995 | 388 | 0.040 |
Why?
|
| Linkage Disequilibrium | 1 | 2022 | 1996 | 0.040 |
Why?
|
| Mice, SCID | 1 | 2003 | 2626 | 0.040 |
Why?
|
| Measles virus | 4 | 1982 | 67 | 0.040 |
Why?
|
| Equipment Design | 2 | 2016 | 3488 | 0.040 |
Why?
|
| Fermentation | 1 | 1998 | 143 | 0.040 |
Why?
|
| Glutathione Transferase | 1 | 1999 | 565 | 0.040 |
Why?
|
| Corpus Striatum | 1 | 2024 | 1218 | 0.040 |
Why?
|
| Mutagenesis, Insertional | 2 | 1998 | 663 | 0.040 |
Why?
|
| Spinal Dysraphism | 1 | 2019 | 179 | 0.040 |
Why?
|
| Birth Injuries | 1 | 1999 | 150 | 0.040 |
Why?
|
| Polymyositis | 1 | 1997 | 75 | 0.040 |
Why?
|
| Protein Kinases | 1 | 2004 | 1610 | 0.040 |
Why?
|
| Brain Injuries | 2 | 2010 | 2053 | 0.040 |
Why?
|
| Histidine | 2 | 1991 | 301 | 0.040 |
Why?
|
| Child, Hospitalized | 1 | 1979 | 181 | 0.040 |
Why?
|
| Vaccinia virus | 2 | 1978 | 328 | 0.030 |
Why?
|
| Aldehydes | 2 | 1989 | 170 | 0.030 |
Why?
|
| Amyloidosis | 1 | 2025 | 877 | 0.030 |
Why?
|
| Paraffin Embedding | 1 | 2018 | 303 | 0.030 |
Why?
|
| Crystallography, X-Ray | 2 | 1999 | 1947 | 0.030 |
Why?
|
| Genome-Wide Association Study | 4 | 2021 | 12808 | 0.030 |
Why?
|
| Schistosoma mansoni | 1 | 1998 | 156 | 0.030 |
Why?
|
| Tissue Fixation | 1 | 2018 | 245 | 0.030 |
Why?
|
| Activities of Daily Living | 2 | 2023 | 2429 | 0.030 |
Why?
|
| Trinitrobenzenesulfonic Acid | 1 | 2016 | 65 | 0.030 |
Why?
|
| Health Facilities | 1 | 2002 | 578 | 0.030 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2021 | 878 | 0.030 |
Why?
|
| Retinal Dehydrogenase | 1 | 1997 | 78 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2000 | 2012 | 0.030 |
Why?
|
| Parents | 1 | 2011 | 3592 | 0.030 |
Why?
|
| Developmental Disabilities | 1 | 2005 | 1519 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2008 | 3139 | 0.030 |
Why?
|
| Intracranial Hypertension | 1 | 1999 | 191 | 0.030 |
Why?
|
| Natural Cytotoxicity Triggering Receptor 2 | 1 | 2016 | 2 | 0.030 |
Why?
|
| Peptidoglycan | 1 | 1998 | 246 | 0.030 |
Why?
|
| Chemical Phenomena | 2 | 1994 | 485 | 0.030 |
Why?
|
| Ganglioglioma | 1 | 1996 | 36 | 0.030 |
Why?
|
| Digestive System | 1 | 1997 | 244 | 0.030 |
Why?
|
| Chromosomes, Fungal | 1 | 1997 | 110 | 0.030 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2017 | 128 | 0.030 |
Why?
|
| Vitamin B 12 | 1 | 1999 | 531 | 0.030 |
Why?
|
| Abnormalities, Multiple | 1 | 2004 | 1424 | 0.030 |
Why?
|
| Population Surveillance | 1 | 2007 | 2594 | 0.030 |
Why?
|
| Pokeweed Mitogens | 2 | 1986 | 37 | 0.030 |
Why?
|
| Injections | 2 | 2017 | 839 | 0.030 |
Why?
|
| Natural Cytotoxicity Triggering Receptor 1 | 1 | 2016 | 29 | 0.030 |
Why?
|
| Formaldehyde | 1 | 2018 | 360 | 0.030 |
Why?
|
| Coronary Disease | 1 | 1991 | 5915 | 0.030 |
Why?
|
| Antibodies, Bacterial | 1 | 2002 | 1477 | 0.030 |
Why?
|
| Luminescent Proteins | 1 | 1999 | 839 | 0.030 |
Why?
|
| Marital Therapy | 1 | 1996 | 44 | 0.030 |
Why?
|
| Cold Temperature | 2 | 1996 | 793 | 0.030 |
Why?
|
| Streptococcus pyogenes | 1 | 1998 | 293 | 0.030 |
Why?
|
| Rabbits | 6 | 1989 | 4752 | 0.030 |
Why?
|
| Oxidation-Reduction | 4 | 1987 | 2221 | 0.030 |
Why?
|
| Lupus Nephritis | 1 | 1999 | 324 | 0.030 |
Why?
|
| Injections, Intradermal | 1 | 1996 | 116 | 0.030 |
Why?
|
| Risk | 3 | 2022 | 9602 | 0.030 |
Why?
|
| Adjustment Disorders | 1 | 1996 | 68 | 0.030 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily K | 1 | 2016 | 94 | 0.030 |
Why?
|
| Cerebrospinal Fluid Pressure | 1 | 1995 | 38 | 0.030 |
Why?
|
| Herpes Zoster | 2 | 1989 | 252 | 0.030 |
Why?
|
| Drug Utilization | 1 | 2002 | 1188 | 0.030 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2017 | 170 | 0.030 |
Why?
|
| Quantitative Trait, Heritable | 1 | 1999 | 540 | 0.030 |
Why?
|
| HLA-DR2 Antigen | 2 | 1993 | 44 | 0.030 |
Why?
|
| Helix-Loop-Helix Motifs | 1 | 1995 | 97 | 0.030 |
Why?
|
| Personality Inventory | 2 | 1996 | 1019 | 0.030 |
Why?
|
| Granulocytes | 1 | 2017 | 551 | 0.030 |
Why?
|
| Urinary Bladder | 1 | 2022 | 1155 | 0.030 |
Why?
|
| Trypsin | 1 | 1996 | 490 | 0.030 |
Why?
|
| Maxilla | 1 | 2019 | 486 | 0.030 |
Why?
|
| alpha-Synuclein | 1 | 2022 | 771 | 0.030 |
Why?
|
| Structure-Activity Relationship | 2 | 2007 | 3053 | 0.030 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2011 | 3724 | 0.030 |
Why?
|
| Leg | 1 | 1980 | 1087 | 0.030 |
Why?
|
| Intracellular Membranes | 1 | 1996 | 386 | 0.030 |
Why?
|
| Kidney | 2 | 2009 | 7073 | 0.030 |
Why?
|
| Platelet Activating Factor | 1 | 2015 | 142 | 0.030 |
Why?
|
| Neuroectodermal Tumors, Primitive | 1 | 1996 | 136 | 0.030 |
Why?
|
| Physician-Patient Relations | 1 | 1989 | 3266 | 0.030 |
Why?
|
| Micelles | 1 | 1996 | 190 | 0.030 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2008 | 3408 | 0.030 |
Why?
|
| Lower Extremity | 1 | 2023 | 1217 | 0.030 |
Why?
|
| Cyclosporine | 1 | 1998 | 778 | 0.030 |
Why?
|
| Histones | 1 | 2006 | 2595 | 0.030 |
Why?
|
| Disease | 1 | 1981 | 675 | 0.030 |
Why?
|
| Infertility | 1 | 2002 | 655 | 0.030 |
Why?
|
| Hybridomas | 2 | 1988 | 442 | 0.030 |
Why?
|
| Pituitary Irradiation | 1 | 1994 | 14 | 0.030 |
Why?
|
| Antigen-Antibody Reactions | 2 | 2012 | 341 | 0.030 |
Why?
|
| Virus Replication | 1 | 1983 | 2457 | 0.030 |
Why?
|
| Neoplasm Proteins | 1 | 1987 | 3600 | 0.030 |
Why?
|
| Sclerosis | 2 | 2008 | 211 | 0.030 |
Why?
|
| Platelet Factor 4 | 1 | 2015 | 131 | 0.030 |
Why?
|
| Cisterna Magna | 3 | 1990 | 39 | 0.030 |
Why?
|
| Chimera | 2 | 1999 | 454 | 0.030 |
Why?
|
| Dandy-Walker Syndrome | 1 | 1995 | 44 | 0.030 |
Why?
|
| Restraint, Physical | 1 | 1996 | 184 | 0.030 |
Why?
|
| Withholding Treatment | 1 | 2019 | 619 | 0.030 |
Why?
|
| Medical History Taking | 1 | 1999 | 779 | 0.030 |
Why?
|
| Chemistry, Physical | 1 | 1994 | 152 | 0.030 |
Why?
|
| Nitriles | 1 | 2020 | 981 | 0.030 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 1976 | 446 | 0.030 |
Why?
|
| Goals | 1 | 2020 | 717 | 0.030 |
Why?
|
| Hypophysectomy | 1 | 1994 | 114 | 0.030 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2023 | 2028 | 0.030 |
Why?
|
| Movement Disorders | 2 | 2011 | 462 | 0.030 |
Why?
|
| Wheelchairs | 1 | 1995 | 78 | 0.030 |
Why?
|
| Body Patterning | 1 | 1999 | 634 | 0.030 |
Why?
|
| Ranvier's Nodes | 1 | 2014 | 19 | 0.030 |
Why?
|
| Cardiolipins | 1 | 1994 | 82 | 0.030 |
Why?
|
| Glucose | 3 | 1998 | 4340 | 0.030 |
Why?
|
| Intraoperative Period | 1 | 2015 | 512 | 0.030 |
Why?
|
| Mumps virus | 2 | 1986 | 23 | 0.030 |
Why?
|
| Electrochemistry | 1 | 1994 | 144 | 0.030 |
Why?
|
| Mice, Inbred CBA | 5 | 1978 | 439 | 0.030 |
Why?
|
| Ki-67 Antigen | 1 | 2017 | 630 | 0.030 |
Why?
|
| Immunologic Techniques | 2 | 1986 | 212 | 0.030 |
Why?
|
| Craniocerebral Trauma | 1 | 1999 | 493 | 0.030 |
Why?
|
| Pheochromocytoma | 1 | 1996 | 327 | 0.030 |
Why?
|
| Lymphokines | 1 | 1997 | 924 | 0.030 |
Why?
|
| History, 19th Century | 1 | 2016 | 714 | 0.030 |
Why?
|
| Sequence Deletion | 2 | 1995 | 1494 | 0.030 |
Why?
|
| Glomerulonephritis, Membranoproliferative | 1 | 1994 | 41 | 0.030 |
Why?
|
| Growth Disorders | 1 | 1999 | 634 | 0.030 |
Why?
|
| Phorbol Esters | 1 | 2013 | 109 | 0.030 |
Why?
|
| HEK293 Cells | 2 | 2013 | 4277 | 0.030 |
Why?
|
| Sirolimus | 2 | 2013 | 1540 | 0.030 |
Why?
|
| Surgical Procedures, Operative | 2 | 1979 | 1931 | 0.030 |
Why?
|
| Neurotransmitter Agents | 2 | 1989 | 661 | 0.030 |
Why?
|
| Poland | 1 | 2014 | 197 | 0.030 |
Why?
|
| Interferon-alpha | 1 | 1998 | 910 | 0.030 |
Why?
|
| Neoplasms | 3 | 2000 | 22350 | 0.030 |
Why?
|
| Microinjections | 5 | 1995 | 319 | 0.030 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 1997 | 646 | 0.030 |
Why?
|
| Selection, Genetic | 1 | 1998 | 877 | 0.030 |
Why?
|
| Lyme Disease | 1 | 1999 | 627 | 0.030 |
Why?
|
| Aerosols | 1 | 1996 | 634 | 0.030 |
Why?
|
| Research | 1 | 2022 | 1977 | 0.030 |
Why?
|
| Discriminant Analysis | 1 | 1993 | 222 | 0.030 |
Why?
|
| Microcomputers | 1 | 1994 | 139 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 1999 | 2062 | 0.030 |
Why?
|
| Equipment Failure Analysis | 1 | 2016 | 832 | 0.030 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2015 | 939 | 0.030 |
Why?
|
| Psychophysiology | 3 | 1985 | 136 | 0.030 |
Why?
|
| Carbachol | 3 | 1990 | 223 | 0.030 |
Why?
|
| Arthritis | 1 | 1998 | 684 | 0.030 |
Why?
|
| Cell Shape | 1 | 2014 | 372 | 0.030 |
Why?
|
| Phantoms, Imaging | 1 | 2001 | 2474 | 0.030 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily B | 1 | 2013 | 85 | 0.030 |
Why?
|
| Histocytochemistry | 2 | 1984 | 697 | 0.030 |
Why?
|
| Sequence Alignment | 1 | 1997 | 2177 | 0.030 |
Why?
|
| Immunization Schedule | 1 | 1994 | 229 | 0.030 |
Why?
|
| Geriatric Psychiatry | 1 | 1993 | 70 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2021 | 16044 | 0.030 |
Why?
|
| Chemokine CXCL9 | 2 | 2004 | 136 | 0.030 |
Why?
|
| Phytohemagglutinins | 2 | 1995 | 164 | 0.030 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 1992 | 220 | 0.030 |
Why?
|
| Head | 1 | 2019 | 926 | 0.030 |
Why?
|
| Biotransformation | 1 | 1993 | 165 | 0.030 |
Why?
|
| Molecular Conformation | 2 | 1989 | 540 | 0.030 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 2013 | 220 | 0.030 |
Why?
|
| Abdomen, Acute | 1 | 1993 | 122 | 0.030 |
Why?
|
| Sepharose | 1 | 1992 | 100 | 0.030 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1994 | 705 | 0.030 |
Why?
|
| Electron Transport Complex IV | 1 | 1993 | 188 | 0.030 |
Why?
|
| Occult Blood | 1 | 1993 | 199 | 0.030 |
Why?
|
| Salvage Therapy | 2 | 2010 | 1274 | 0.030 |
Why?
|
| Registries | 2 | 2021 | 8352 | 0.030 |
Why?
|
| Genes, BRCA2 | 1 | 2015 | 591 | 0.030 |
Why?
|
| Protein Folding | 1 | 1996 | 869 | 0.030 |
Why?
|
| Gangliosides | 1 | 2013 | 132 | 0.030 |
Why?
|
| CD4-CD8 Ratio | 1 | 1992 | 114 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 1996 | 1887 | 0.030 |
Why?
|
| Atrial Fibrillation | 1 | 1991 | 5182 | 0.020 |
Why?
|
| Dominance-Subordination | 1 | 1992 | 26 | 0.020 |
Why?
|
| Microscopy, Electron | 2 | 2008 | 2551 | 0.020 |
Why?
|
| Inositol | 1 | 2013 | 215 | 0.020 |
Why?
|
| Spinal Cord Diseases | 1 | 2015 | 291 | 0.020 |
Why?
|
| Tilapia | 1 | 1992 | 24 | 0.020 |
Why?
|
| Cell Degranulation | 1 | 2013 | 276 | 0.020 |
Why?
|
| Cholera Toxin | 1 | 1994 | 562 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 2003 | 2979 | 0.020 |
Why?
|
| Glycosuria | 1 | 1991 | 44 | 0.020 |
Why?
|
| Myelin P2 Protein | 2 | 1989 | 20 | 0.020 |
Why?
|
| Electroshock | 2 | 1989 | 120 | 0.020 |
Why?
|
| Genes, BRCA1 | 1 | 2015 | 753 | 0.020 |
Why?
|
| Diagnostic Techniques, Neurological | 1 | 2012 | 62 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 1999 | 2629 | 0.020 |
Why?
|
| Swine | 3 | 1996 | 5985 | 0.020 |
Why?
|
| Pituitary Gland | 1 | 1994 | 635 | 0.020 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2010 | 5753 | 0.020 |
Why?
|
| Renin | 1 | 1994 | 647 | 0.020 |
Why?
|
| Rehabilitation | 2 | 1963 | 129 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 1998 | 3093 | 0.020 |
Why?
|
| Naltrexone | 2 | 1992 | 319 | 0.020 |
Why?
|
| Bisexuality | 1 | 1994 | 295 | 0.020 |
Why?
|
| Culture Techniques | 2 | 1988 | 529 | 0.020 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 1995 | 892 | 0.020 |
Why?
|
| Isoelectric Point | 1 | 1991 | 76 | 0.020 |
Why?
|
| Listeriosis | 1 | 2012 | 147 | 0.020 |
Why?
|
| Transplantation Immunology | 1 | 1994 | 540 | 0.020 |
Why?
|
| Patient-Centered Care | 1 | 2022 | 1445 | 0.020 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2023 | 2809 | 0.020 |
Why?
|
| Eating | 2 | 1989 | 1539 | 0.020 |
Why?
|
| Duodenal Ulcer | 1 | 1991 | 117 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 2 | 1990 | 1305 | 0.020 |
Why?
|
| Consensus | 1 | 2021 | 3208 | 0.020 |
Why?
|
| Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor | 1 | 1991 | 40 | 0.020 |
Why?
|
| Diplopia | 1 | 1993 | 217 | 0.020 |
Why?
|
| Integrin alpha4beta1 | 1 | 2011 | 119 | 0.020 |
Why?
|
| DNA Probes | 3 | 2003 | 541 | 0.020 |
Why?
|
| Mammals | 1 | 1997 | 1133 | 0.020 |
Why?
|
| Kainic Acid | 1 | 1991 | 203 | 0.020 |
Why?
|
| Absenteeism | 1 | 2012 | 247 | 0.020 |
Why?
|
| Choline | 1 | 2013 | 511 | 0.020 |
Why?
|
| Bombesin | 1 | 1990 | 35 | 0.020 |
Why?
|
| Occipital Lobe | 1 | 1993 | 376 | 0.020 |
Why?
|
| Peritonitis | 1 | 1993 | 368 | 0.020 |
Why?
|
| Epithelium | 2 | 1999 | 1606 | 0.020 |
Why?
|
| Neuropeptides | 1 | 1996 | 950 | 0.020 |
Why?
|
| Cerebral Hemorrhage | 1 | 2002 | 2654 | 0.020 |
Why?
|
| Creatine | 1 | 2013 | 424 | 0.020 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 1996 | 732 | 0.020 |
Why?
|
| Lipid A | 1 | 1990 | 70 | 0.020 |
Why?
|
| Listeria monocytogenes | 1 | 2012 | 246 | 0.020 |
Why?
|
| Alcohols | 1 | 1991 | 94 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2018 | 8623 | 0.020 |
Why?
|
| NFATC Transcription Factors | 1 | 2012 | 393 | 0.020 |
Why?
|
| Mitogens | 2 | 1989 | 229 | 0.020 |
Why?
|
| Videotape Recording | 2 | 2002 | 334 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2012 | 685 | 0.020 |
Why?
|
| Thoracic Vertebrae | 1 | 2015 | 613 | 0.020 |
Why?
|
| Genetic Complementation Test | 1 | 1991 | 556 | 0.020 |
Why?
|
| Visual Cortex | 1 | 2018 | 1081 | 0.020 |
Why?
|
| Oleic Acid | 1 | 1990 | 89 | 0.020 |
Why?
|
| Oleic Acids | 1 | 1990 | 71 | 0.020 |
Why?
|
| Chromatin | 1 | 2022 | 2980 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 1997 | 1874 | 0.020 |
Why?
|
| Disease Management | 1 | 2021 | 2533 | 0.020 |
Why?
|
| HLA-C Antigens | 1 | 2010 | 146 | 0.020 |
Why?
|
| Amino Acid Motifs | 1 | 2012 | 928 | 0.020 |
Why?
|
| Spinal Stenosis | 1 | 1993 | 259 | 0.020 |
Why?
|
| Molecular Sequence Annotation | 1 | 2012 | 526 | 0.020 |
Why?
|
| Chemokine CCL4 | 2 | 2000 | 126 | 0.020 |
Why?
|
| HLA-A Antigens | 1 | 2010 | 223 | 0.020 |
Why?
|
| DNA, Fungal | 1 | 1991 | 275 | 0.020 |
Why?
|
| Butanols | 1 | 1989 | 19 | 0.020 |
Why?
|
| Chemokine CCL5 | 2 | 2000 | 214 | 0.020 |
Why?
|
| Antiviral Agents | 1 | 2022 | 3070 | 0.020 |
Why?
|
| Concanavalin A | 2 | 1980 | 189 | 0.020 |
Why?
|
| Oligonucleotide Probes | 1 | 1990 | 416 | 0.020 |
Why?
|
| Psychomotor Performance | 1 | 1998 | 1885 | 0.020 |
Why?
|
| Deoxyglucose | 2 | 1988 | 322 | 0.020 |
Why?
|
| Immunoglobulin E | 3 | 1990 | 1495 | 0.020 |
Why?
|
| Indomethacin | 1 | 1990 | 323 | 0.020 |
Why?
|
| Placebo Effect | 1 | 1993 | 515 | 0.020 |
Why?
|
| Fibroblast Growth Factor 1 | 1 | 1989 | 53 | 0.020 |
Why?
|
| Rats, Brattleboro | 1 | 1989 | 37 | 0.020 |
Why?
|
| Pancreatic Diseases | 1 | 1991 | 353 | 0.020 |
Why?
|
| Rats, Mutant Strains | 1 | 1989 | 60 | 0.020 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 1994 | 1788 | 0.020 |
Why?
|
| Likelihood Functions | 1 | 2012 | 993 | 0.020 |
Why?
|
| Urine | 1 | 1971 | 363 | 0.020 |
Why?
|
| Models, Genetic | 2 | 2010 | 3446 | 0.020 |
Why?
|
| Macrophages, Peritoneal | 1 | 2010 | 244 | 0.020 |
Why?
|
| Cytotoxicity Tests, Immunologic | 3 | 1978 | 317 | 0.020 |
Why?
|
| Pattern Recognition, Automated | 1 | 2015 | 980 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 2 | 2011 | 2694 | 0.020 |
Why?
|
| Prostaglandins | 1 | 1990 | 398 | 0.020 |
Why?
|
| Arginine Vasopressin | 1 | 1989 | 125 | 0.020 |
Why?
|
| Rett Syndrome | 1 | 2010 | 164 | 0.020 |
Why?
|
| Rats, Inbred BN | 3 | 1993 | 229 | 0.020 |
Why?
|
| Preoperative Period | 1 | 2011 | 564 | 0.020 |
Why?
|
| Reticulocytes | 1 | 1989 | 287 | 0.020 |
Why?
|
| Sensation | 2 | 1986 | 331 | 0.020 |
Why?
|
| Metagenome | 1 | 2012 | 464 | 0.020 |
Why?
|
| Cebidae | 1 | 1988 | 21 | 0.020 |
Why?
|
| Presenilin-1 | 1 | 2013 | 665 | 0.020 |
Why?
|
| Streptomycin | 1 | 1968 | 69 | 0.020 |
Why?
|
| Satiation | 1 | 1989 | 84 | 0.020 |
Why?
|
| Affect | 1 | 1996 | 1494 | 0.020 |
Why?
|
| Rosette Formation | 2 | 1978 | 152 | 0.020 |
Why?
|
| Muscle, Smooth | 2 | 1991 | 930 | 0.020 |
Why?
|
| Antibodies, Antinuclear | 1 | 2010 | 340 | 0.020 |
Why?
|
| Polyneuropathies | 1 | 1990 | 139 | 0.020 |
Why?
|
| Diabetes Insipidus | 1 | 1989 | 144 | 0.020 |
Why?
|
| Sequence Analysis | 1 | 2009 | 240 | 0.020 |
Why?
|
| Genome | 1 | 1996 | 1753 | 0.020 |
Why?
|
| Solvents | 1 | 1989 | 299 | 0.020 |
Why?
|
| Body Temperature | 1 | 1991 | 780 | 0.020 |
Why?
|
| Tyrosine | 1 | 2012 | 1425 | 0.020 |
Why?
|
| Interleukin-13 | 1 | 2010 | 391 | 0.020 |
Why?
|
| Injections, Intramuscular | 1 | 1989 | 551 | 0.020 |
Why?
|
| Colorimetry | 1 | 1988 | 147 | 0.020 |
Why?
|
| Streptomyces | 1 | 1968 | 91 | 0.020 |
Why?
|
| Alanine | 1 | 1991 | 613 | 0.020 |
Why?
|
| Immunoglobulin Isotypes | 1 | 1988 | 158 | 0.020 |
Why?
|
| Cerebral Angiography | 1 | 1993 | 1263 | 0.020 |
Why?
|
| Cytoplasm | 1 | 2012 | 1505 | 0.020 |
Why?
|
| Herpesvirus 3, Human | 1 | 1989 | 159 | 0.020 |
Why?
|
| Virulence | 2 | 1983 | 1294 | 0.020 |
Why?
|
| Electrocardiography | 2 | 1991 | 6408 | 0.020 |
Why?
|
| Imipramine | 1 | 1987 | 96 | 0.020 |
Why?
|
| Jews | 1 | 1969 | 359 | 0.020 |
Why?
|
| Muscle Contraction | 2 | 1991 | 1208 | 0.020 |
Why?
|
| Telephone | 1 | 1991 | 629 | 0.020 |
Why?
|
| Linear Models | 1 | 2017 | 5873 | 0.020 |
Why?
|
| Pentaerythritol Tetranitrate | 1 | 2007 | 2 | 0.020 |
Why?
|
| Boston | 1 | 2020 | 9346 | 0.020 |
Why?
|
| Homosexuality, Male | 1 | 1995 | 1342 | 0.020 |
Why?
|
| Glyceraldehyde | 1 | 1987 | 5 | 0.020 |
Why?
|
| Giant Cells | 1 | 2008 | 187 | 0.020 |
Why?
|
| Blotting, Northern | 1 | 1989 | 1550 | 0.020 |
Why?
|
| Saimiri | 1 | 1988 | 337 | 0.020 |
Why?
|
| Weight Loss | 3 | 2001 | 2712 | 0.020 |
Why?
|
| Cyclic GMP-Dependent Protein Kinases | 1 | 2007 | 28 | 0.020 |
Why?
|
| Achievement | 2 | 1973 | 287 | 0.020 |
Why?
|
| Germ-Line Mutation | 1 | 2015 | 1886 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2015 | 3552 | 0.020 |
Why?
|
| Resuscitation | 2 | 2002 | 681 | 0.020 |
Why?
|
| Vimentin | 1 | 2008 | 257 | 0.020 |
Why?
|
| Fungal Proteins | 1 | 1991 | 901 | 0.020 |
Why?
|
| Aggression | 1 | 1992 | 748 | 0.020 |
Why?
|
| Morphine | 2 | 1989 | 658 | 0.020 |
Why?
|
| Oxadiazoles | 1 | 2007 | 94 | 0.020 |
Why?
|
| Radionuclide Imaging | 1 | 2011 | 1986 | 0.020 |
Why?
|
| Amenorrhea | 2 | 1989 | 470 | 0.020 |
Why?
|
| Nerve Tissue | 1 | 1987 | 77 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 1998 | 4780 | 0.020 |
Why?
|
| Cartilage | 1 | 1990 | 811 | 0.020 |
Why?
|
| Nitroprusside | 1 | 2007 | 271 | 0.020 |
Why?
|
| Injections, Intraventricular | 1 | 1987 | 227 | 0.020 |
Why?
|
| ROC Curve | 1 | 2014 | 3621 | 0.020 |
Why?
|
| Cortical Synchronization | 1 | 2007 | 76 | 0.020 |
Why?
|
| Luminescence | 1 | 2007 | 108 | 0.020 |
Why?
|
| Isometric Contraction | 1 | 2007 | 149 | 0.020 |
Why?
|
| Drug Hypersensitivity | 1 | 1995 | 903 | 0.020 |
Why?
|
| Immunologic Surveillance | 1 | 1987 | 92 | 0.020 |
Why?
|
| Dogs | 1 | 1991 | 3834 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 1994 | 3610 | 0.020 |
Why?
|
| Prednisone | 2 | 1982 | 1566 | 0.020 |
Why?
|
| Camptothecin | 1 | 2010 | 599 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2019 | 3582 | 0.020 |
Why?
|
| Skin Tests | 1 | 1988 | 630 | 0.020 |
Why?
|
| Retina | 1 | 1997 | 2660 | 0.020 |
Why?
|
| Vaccines, Attenuated | 1 | 1987 | 314 | 0.020 |
Why?
|
| Pyrimidines | 1 | 2018 | 3043 | 0.020 |
Why?
|
| Tuberculosis, Pulmonary | 2 | 1963 | 836 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2011 | 2274 | 0.020 |
Why?
|
| Cerebrovascular Disorders | 1 | 2013 | 1478 | 0.020 |
Why?
|
| Nucleic Acid Conformation | 1 | 1989 | 899 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2010 | 12246 | 0.020 |
Why?
|
| Intermediate Filament Proteins | 1 | 1987 | 261 | 0.020 |
Why?
|
| Immunoglobulin Fc Fragments | 2 | 1978 | 287 | 0.020 |
Why?
|
| Electrodes | 2 | 2007 | 612 | 0.020 |
Why?
|
| Triiodothyronine | 1 | 1987 | 493 | 0.020 |
Why?
|
| Hypertension | 3 | 1994 | 8616 | 0.020 |
Why?
|
| Psychometrics | 1 | 1995 | 3060 | 0.020 |
Why?
|
| Debridement | 1 | 2008 | 494 | 0.020 |
Why?
|
| Neural Inhibition | 1 | 1990 | 589 | 0.020 |
Why?
|
| Mitochondria, Muscle | 1 | 2007 | 171 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2019 | 3942 | 0.020 |
Why?
|
| Blood Cells | 1 | 1987 | 309 | 0.020 |
Why?
|
| Cerebral Palsy | 1 | 2010 | 480 | 0.020 |
Why?
|
| Immunologic Tests | 1 | 2006 | 101 | 0.020 |
Why?
|
| Social Isolation | 1 | 1989 | 366 | 0.020 |
Why?
|
| Nitroglycerin | 1 | 2007 | 332 | 0.020 |
Why?
|
| Walking | 1 | 2013 | 1201 | 0.020 |
Why?
|
| Receptors, Neurotransmitter | 1 | 1985 | 171 | 0.020 |
Why?
|
| Dietary Supplements | 1 | 2018 | 3429 | 0.020 |
Why?
|
| Exercise | 1 | 2022 | 5945 | 0.020 |
Why?
|
| Time | 1 | 2007 | 550 | 0.020 |
Why?
|
| Cytoplasmic Granules | 1 | 1988 | 574 | 0.020 |
Why?
|
| Luteinizing Hormone | 2 | 1981 | 828 | 0.020 |
Why?
|
| Diethyl Pyrocarbonate | 1 | 1985 | 5 | 0.020 |
Why?
|
| Immunoblotting | 1 | 1988 | 1647 | 0.020 |
Why?
|
| Translocation, Genetic | 1 | 1991 | 1392 | 0.020 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2020 | 3683 | 0.020 |
Why?
|
| Mesna | 1 | 2004 | 62 | 0.020 |
Why?
|
| DNA Transposable Elements | 1 | 1989 | 764 | 0.020 |
Why?
|
| Survivors | 1 | 2015 | 2379 | 0.020 |
Why?
|
| Radioimmunoassay | 2 | 1983 | 861 | 0.010 |
Why?
|
| Gonadal Steroid Hormones | 1 | 1989 | 706 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 2 | 1999 | 4523 | 0.010 |
Why?
|
| Neutropenia | 1 | 2010 | 895 | 0.010 |
Why?
|
| Quinoxalines | 1 | 2007 | 297 | 0.010 |
Why?
|
| Time Perception | 1 | 1965 | 87 | 0.010 |
Why?
|
| Ribosomal Protein S6 | 1 | 2004 | 70 | 0.010 |
Why?
|
| Family | 1 | 2015 | 3209 | 0.010 |
Why?
|
| Area Under Curve | 1 | 2009 | 1639 | 0.010 |
Why?
|
| Herpes Simplex | 1 | 1988 | 470 | 0.010 |
Why?
|
| Proteoglycans | 1 | 2008 | 806 | 0.010 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2004 | 102 | 0.010 |
Why?
|
| Polymorphism, Genetic | 2 | 1993 | 4249 | 0.010 |
Why?
|
| Eukaryotic Initiation Factors | 1 | 2004 | 83 | 0.010 |
Why?
|
| Prevalence | 2 | 2010 | 15835 | 0.010 |
Why?
|
| Hypersensitivity | 1 | 1994 | 1168 | 0.010 |
Why?
|
| Methicillin Resistance | 1 | 2005 | 198 | 0.010 |
Why?
|
| Infusion Pumps | 1 | 2005 | 163 | 0.010 |
Why?
|
| Microdissection | 1 | 2004 | 150 | 0.010 |
Why?
|
| Chemokine CXCL11 | 1 | 2004 | 42 | 0.010 |
Why?
|
| Anxiety Disorders | 1 | 1995 | 2743 | 0.010 |
Why?
|
| Plasmids | 1 | 1989 | 2268 | 0.010 |
Why?
|
| Lymphocytes, Null | 1 | 1983 | 13 | 0.010 |
Why?
|
| Risk Assessment | 2 | 2015 | 24299 | 0.010 |
Why?
|
| Gene Amplification | 2 | 1991 | 1088 | 0.010 |
Why?
|
| Gene Dosage | 1 | 2008 | 1211 | 0.010 |
Why?
|
| Surgical Wound Infection | 1 | 1993 | 1547 | 0.010 |
Why?
|
| Ultraviolet Therapy | 1 | 1984 | 82 | 0.010 |
Why?
|
| L-Selectin | 1 | 2004 | 212 | 0.010 |
Why?
|
| Receptors, Cell Surface | 1 | 2013 | 2815 | 0.010 |
Why?
|
| Meningitis | 1 | 2005 | 219 | 0.010 |
Why?
|
| Genetic Engineering | 1 | 1989 | 936 | 0.010 |
Why?
|
| Odds Ratio | 2 | 2010 | 9661 | 0.010 |
Why?
|
| Galvanic Skin Response | 1 | 1965 | 359 | 0.010 |
Why?
|
| Immune Sera | 3 | 1982 | 605 | 0.010 |
Why?
|
| Tetrahydrofolate Dehydrogenase | 1 | 1983 | 133 | 0.010 |
Why?
|
| Etoposide | 1 | 2004 | 638 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 1987 | 2275 | 0.010 |
Why?
|
| Mathematics | 2 | 1981 | 696 | 0.010 |
Why?
|
| Whole-Body Irradiation | 1 | 1984 | 438 | 0.010 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2004 | 271 | 0.010 |
Why?
|
| Age Distribution | 1 | 2009 | 2869 | 0.010 |
Why?
|
| Hemophilia A | 1 | 2006 | 359 | 0.010 |
Why?
|
| Body Weight | 5 | 1982 | 4626 | 0.010 |
Why?
|
| Leucovorin | 1 | 2004 | 644 | 0.010 |
Why?
|
| Collagen Type IV | 1 | 2003 | 125 | 0.010 |
Why?
|
| Drug Synergism | 2 | 2002 | 1757 | 0.010 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 1987 | 698 | 0.010 |
Why?
|
| Chemokine CCL7 | 1 | 2002 | 30 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1985 | 1622 | 0.010 |
Why?
|
| Rheumatic Fever | 1 | 1982 | 73 | 0.010 |
Why?
|
| Monocyte Chemoattractant Proteins | 1 | 2002 | 48 | 0.010 |
Why?
|
| Lymphotoxin beta Receptor | 1 | 2002 | 26 | 0.010 |
Why?
|
| Salsoline Alkaloids | 1 | 1982 | 1 | 0.010 |
Why?
|
| Vasodilator Agents | 1 | 2007 | 988 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2016 | 6258 | 0.010 |
Why?
|
| Paramyxoviridae | 1 | 1982 | 9 | 0.010 |
Why?
|
| Polyradiculoneuropathy | 1 | 1982 | 65 | 0.010 |
Why?
|
| Coronaviridae | 1 | 1982 | 13 | 0.010 |
Why?
|
| Obesity | 3 | 2021 | 13090 | 0.010 |
Why?
|
| Picornaviridae | 1 | 1982 | 14 | 0.010 |
Why?
|
| Parainfluenza Virus 3, Human | 1 | 1982 | 25 | 0.010 |
Why?
|
| Veratrum Alkaloids | 1 | 2001 | 23 | 0.010 |
Why?
|
| Thrombocytopenia | 1 | 2010 | 1172 | 0.010 |
Why?
|
| Vincristine | 1 | 2004 | 1040 | 0.010 |
Why?
|
| Tectum Mesencephali | 1 | 2001 | 18 | 0.010 |
Why?
|
| Pronase | 1 | 1981 | 28 | 0.010 |
Why?
|
| Sodium Azide | 1 | 1981 | 24 | 0.010 |
Why?
|
| Chorea | 1 | 1982 | 80 | 0.010 |
Why?
|
| Cytochalasin B | 1 | 1981 | 74 | 0.010 |
Why?
|
| Radiation Chimera | 2 | 1984 | 216 | 0.010 |
Why?
|
| Breast Implantation | 1 | 2005 | 225 | 0.010 |
Why?
|
| Immunoglobulin lambda-Chains | 1 | 1982 | 84 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 2000 | 5888 | 0.010 |
Why?
|
| Receptors, Antigen | 1 | 1982 | 51 | 0.010 |
Why?
|
| Indicators and Reagents | 1 | 2002 | 456 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2001 | 8108 | 0.010 |
Why?
|
| Bucladesine | 1 | 2001 | 118 | 0.010 |
Why?
|
| Motor Neurons | 1 | 1987 | 869 | 0.010 |
Why?
|
| Azides | 1 | 1981 | 120 | 0.010 |
Why?
|
| Nerve Crush | 1 | 2001 | 77 | 0.010 |
Why?
|
| Hematopoiesis | 1 | 1971 | 2060 | 0.010 |
Why?
|
| Paraneoplastic Syndromes | 1 | 1982 | 154 | 0.010 |
Why?
|
| Arrhythmias, Cardiac | 1 | 1991 | 2257 | 0.010 |
Why?
|
| Macaca nemestrina | 1 | 1980 | 19 | 0.010 |
Why?
|
| Immunoglobulin Light Chains | 1 | 1982 | 289 | 0.010 |
Why?
|
| Polyomavirus | 1 | 1982 | 236 | 0.010 |
Why?
|
| Neuroma, Acoustic | 1 | 2005 | 456 | 0.010 |
Why?
|
| Early Diagnosis | 1 | 2006 | 1186 | 0.010 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 1 | 2001 | 318 | 0.010 |
Why?
|
| Clomiphene | 1 | 1981 | 71 | 0.010 |
Why?
|
| Receptors, CCR1 | 1 | 2000 | 30 | 0.010 |
Why?
|
| Child Behavior Disorders | 1 | 2005 | 812 | 0.010 |
Why?
|
| Electrolytes | 1 | 2001 | 279 | 0.010 |
Why?
|
| Orthomyxoviridae | 1 | 1982 | 148 | 0.010 |
Why?
|
| Atrial Natriuretic Factor | 1 | 2001 | 350 | 0.010 |
Why?
|
| Language Disorders | 1 | 2001 | 140 | 0.010 |
Why?
|
| Cell Adhesion Molecules | 1 | 2007 | 1612 | 0.010 |
Why?
|
| Vitamin D | 1 | 2014 | 3270 | 0.010 |
Why?
|
| Hematocrit | 1 | 2002 | 622 | 0.010 |
Why?
|
| Fenclonine | 2 | 1990 | 16 | 0.010 |
Why?
|
| Clinical Protocols | 1 | 2006 | 1438 | 0.010 |
Why?
|
| Colchicine | 1 | 1981 | 257 | 0.010 |
Why?
|
| Iodine Radioisotopes | 1 | 1984 | 1030 | 0.010 |
Why?
|
| Vasopressins | 1 | 2001 | 358 | 0.010 |
Why?
|
| Pandemics | 1 | 2020 | 8734 | 0.010 |
Why?
|
| Epinephrine | 1 | 1983 | 782 | 0.010 |
Why?
|
| Blotting, Southern | 2 | 1991 | 774 | 0.010 |
Why?
|
| Tuberculosis | 2 | 1963 | 2011 | 0.010 |
Why?
|
| Capillaries | 1 | 1983 | 755 | 0.010 |
Why?
|
| Gonadotropins | 1 | 1981 | 241 | 0.010 |
Why?
|
| Coturnix | 1 | 1999 | 22 | 0.010 |
Why?
|
| Mice, Inbred MRL lpr | 1 | 1999 | 159 | 0.010 |
Why?
|
| Transplantation, Autologous | 1 | 2004 | 2127 | 0.010 |
Why?
|
| Menstruation Disturbances | 1 | 1981 | 140 | 0.010 |
Why?
|
| Pulmonary Embolism | 1 | 1993 | 2596 | 0.010 |
Why?
|
| Hydroxyquinolines | 1 | 1999 | 17 | 0.010 |
Why?
|
| Chemokine CCL3 | 1 | 1999 | 84 | 0.010 |
Why?
|
| Paralysis | 1 | 2001 | 250 | 0.010 |
Why?
|
| Sodium Chloride | 1 | 2001 | 580 | 0.010 |
Why?
|
| Placebos | 1 | 1984 | 1659 | 0.010 |
Why?
|
| Models, Theoretical | 2 | 1987 | 3563 | 0.010 |
Why?
|
| Fibroblast Growth Factor 8 | 1 | 1999 | 62 | 0.010 |
Why?
|
| Heterozygote | 2 | 1996 | 2795 | 0.010 |
Why?
|
| Rorschach Test | 1 | 1979 | 26 | 0.010 |
Why?
|
| Rhombencephalon | 1 | 1999 | 81 | 0.010 |
Why?
|
| Mice, Inbred C3H | 1 | 1980 | 915 | 0.010 |
Why?
|
| gamma-Globulins | 2 | 1976 | 119 | 0.010 |
Why?
|
| Heart Ventricles | 1 | 1991 | 3831 | 0.010 |
Why?
|
| Interleukin-8 | 1 | 2002 | 703 | 0.010 |
Why?
|
| Hindlimb | 1 | 2001 | 513 | 0.010 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2004 | 1150 | 0.010 |
Why?
|
| Classification | 1 | 1979 | 128 | 0.010 |
Why?
|
| Androgens | 2 | 1981 | 1280 | 0.010 |
Why?
|
| Software Design | 1 | 1999 | 173 | 0.010 |
Why?
|
| Neoadjuvant Therapy | 1 | 2010 | 2902 | 0.010 |
Why?
|
| Hemagglutination | 1 | 1978 | 32 | 0.010 |
Why?
|
| Lymphocyte Cooperation | 1 | 1978 | 112 | 0.010 |
Why?
|
| Centromere | 1 | 1999 | 214 | 0.010 |
Why?
|
| Cisplatin | 1 | 2004 | 1656 | 0.010 |
Why?
|
| Breast Neoplasms | 3 | 2015 | 21162 | 0.010 |
Why?
|
| Patient Compliance | 1 | 1989 | 2694 | 0.010 |
Why?
|
| Random Allocation | 1 | 1983 | 2394 | 0.010 |
Why?
|
| Carbon Isotopes | 2 | 1969 | 453 | 0.010 |
Why?
|
| Simplexvirus | 1 | 1982 | 805 | 0.010 |
Why?
|
| Genetic Code | 1 | 1978 | 139 | 0.010 |
Why?
|
| Massachusetts | 1 | 2011 | 8890 | 0.010 |
Why?
|
| Hybridization, Genetic | 1 | 1977 | 102 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 2007 | 2448 | 0.010 |
Why?
|
| Constriction, Pathologic | 1 | 2001 | 1104 | 0.010 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2001 | 617 | 0.010 |
Why?
|
| Muscles | 2 | 1980 | 1576 | 0.010 |
Why?
|
| Blood Loss, Surgical | 1 | 2002 | 642 | 0.010 |
Why?
|
| Adenoviridae | 1 | 1982 | 1093 | 0.010 |
Why?
|
| Isoelectric Focusing | 1 | 1977 | 148 | 0.010 |
Why?
|
| Leukemia | 1 | 1986 | 1521 | 0.010 |
Why?
|
| Tetrahydropapaveroline | 1 | 1977 | 2 | 0.010 |
Why?
|
| 3,4-Dihydroxyphenylacetic Acid | 1 | 1977 | 60 | 0.010 |
Why?
|
| Chick Embryo | 1 | 1999 | 973 | 0.010 |
Why?
|
| Immunoglobulin alpha-Chains | 1 | 1976 | 8 | 0.010 |
Why?
|
| Synovitis | 1 | 1998 | 217 | 0.010 |
Why?
|
| Endocytosis | 1 | 2001 | 951 | 0.010 |
Why?
|
| Immunoglobulin gamma-Chains | 1 | 1976 | 33 | 0.010 |
Why?
|
| Muscular Dystrophies | 1 | 1979 | 393 | 0.010 |
Why?
|
| Personality | 1 | 1981 | 560 | 0.010 |
Why?
|
| Blood Cell Count | 1 | 1978 | 405 | 0.010 |
Why?
|
| Neovascularization, Pathologic | 1 | 1987 | 2631 | 0.010 |
Why?
|
| Life Tables | 1 | 1997 | 367 | 0.010 |
Why?
|
| Enzyme Stability | 1 | 1997 | 218 | 0.010 |
Why?
|
| Feedback | 1 | 1981 | 797 | 0.010 |
Why?
|
| Transplants | 1 | 1999 | 209 | 0.010 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 1979 | 392 | 0.010 |
Why?
|
| Aldosterone | 1 | 2001 | 881 | 0.010 |
Why?
|
| Rats, Inbred BB | 1 | 1996 | 29 | 0.010 |
Why?
|
| Posture | 1 | 1980 | 955 | 0.010 |
Why?
|
| Sodium | 1 | 2001 | 1594 | 0.010 |
Why?
|
| Diagnostic Imaging | 1 | 2010 | 3530 | 0.010 |
Why?
|
| Staphylococcal Infections | 1 | 2005 | 1396 | 0.010 |
Why?
|
| Psychoneuroimmunology | 1 | 1995 | 13 | 0.010 |
Why?
|
| Consanguinity | 1 | 1978 | 460 | 0.010 |
Why?
|
| Oligosaccharides | 1 | 1998 | 406 | 0.010 |
Why?
|
| Lectins | 1 | 1978 | 490 | 0.010 |
Why?
|
| Poly I-C | 1 | 1996 | 110 | 0.010 |
Why?
|
| Drug Evaluation | 1 | 1997 | 642 | 0.010 |
Why?
|
| Embryo, Nonmammalian | 1 | 1999 | 910 | 0.010 |
Why?
|
| Milk | 1 | 1978 | 436 | 0.010 |
Why?
|
| Cell Wall | 1 | 1998 | 419 | 0.010 |
Why?
|
| Capsid | 1 | 1978 | 435 | 0.010 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2004 | 2060 | 0.010 |
Why?
|
| Metals | 1 | 1980 | 711 | 0.010 |
Why?
|
| Cranial Nerve Injuries | 1 | 1995 | 27 | 0.010 |
Why?
|
| Retinal Ganglion Cells | 1 | 2001 | 810 | 0.010 |
Why?
|
| Wnt Proteins | 1 | 1999 | 722 | 0.010 |
Why?
|
| Blood Transfusion | 1 | 2002 | 1308 | 0.010 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 1981 | 1142 | 0.010 |
Why?
|
| Temperature | 1 | 1981 | 2231 | 0.010 |
Why?
|
| Antigens, Neoplasm | 1 | 1982 | 1998 | 0.010 |
Why?
|
| Lymphoma | 1 | 1984 | 1899 | 0.010 |
Why?
|
| Superantigens | 1 | 1994 | 124 | 0.010 |
Why?
|
| Gene Transfer Techniques | 1 | 1999 | 1206 | 0.010 |
Why?
|
| Colon | 1 | 2002 | 1797 | 0.010 |
Why?
|
| Radiotherapy | 1 | 2001 | 1497 | 0.010 |
Why?
|
| Receptors, Interleukin-1 | 1 | 1995 | 260 | 0.010 |
Why?
|
| Cats | 2 | 1972 | 972 | 0.010 |
Why?
|
| Gene Library | 1 | 1997 | 1065 | 0.010 |
Why?
|
| Estrogens | 1 | 1981 | 1528 | 0.010 |
Why?
|
| Genes, Dominant | 1 | 1996 | 855 | 0.010 |
Why?
|
| HLA-DQ Antigens | 1 | 1994 | 190 | 0.010 |
Why?
|
| Mental Disorders | 2 | 1993 | 6869 | 0.010 |
Why?
|
| Mastectomy | 1 | 1982 | 1861 | 0.010 |
Why?
|
| Telomere | 1 | 1999 | 943 | 0.010 |
Why?
|
| Rats, Inbred WF | 1 | 1992 | 139 | 0.010 |
Why?
|
| Observer Variation | 1 | 1999 | 2614 | 0.010 |
Why?
|
| Infant, Premature | 1 | 2002 | 2120 | 0.010 |
Why?
|
| Interleukin-7 | 1 | 1993 | 146 | 0.010 |
Why?
|
| Vasodilation | 1 | 1996 | 968 | 0.010 |
Why?
|
| Safety | 1 | 1997 | 1157 | 0.010 |
Why?
|
| Cerebellar Nuclei | 1 | 1972 | 54 | 0.010 |
Why?
|
| Virus Diseases | 1 | 1978 | 721 | 0.010 |
Why?
|
| Psychosomatic Medicine | 1 | 1972 | 72 | 0.010 |
Why?
|
| Thalamic Nuclei | 1 | 1972 | 110 | 0.010 |
Why?
|
| Haplorhini | 1 | 1972 | 520 | 0.010 |
Why?
|
| Anger | 1 | 1994 | 402 | 0.010 |
Why?
|
| Neurophysiology | 1 | 1972 | 144 | 0.010 |
Why?
|
| Pineal Gland | 1 | 1972 | 158 | 0.010 |
Why?
|
| Raphe Nuclei | 1 | 1991 | 104 | 0.010 |
Why?
|
| Homozygote | 1 | 1995 | 1775 | 0.010 |
Why?
|
| Bethanechol Compounds | 1 | 1989 | 10 | 0.010 |
Why?
|
| Bethanechol | 1 | 1989 | 12 | 0.010 |
Why?
|
| Aminopyrine | 1 | 1969 | 5 | 0.010 |
Why?
|
| Radioisotope Dilution Technique | 1 | 1969 | 70 | 0.010 |
Why?
|
| Nedocromil | 1 | 1989 | 45 | 0.010 |
Why?
|
| Biological Clocks | 1 | 1972 | 320 | 0.010 |
Why?
|
| Chloramphenicol | 1 | 1969 | 67 | 0.010 |
Why?
|
| Touch | 1 | 1972 | 313 | 0.010 |
Why?
|
| Homeodomain Proteins | 1 | 1999 | 2429 | 0.010 |
Why?
|
| Norepinephrine | 1 | 1972 | 898 | 0.010 |
Why?
|
| Leukocytosis | 1 | 1971 | 249 | 0.010 |
Why?
|
| Vagotomy | 1 | 1989 | 82 | 0.010 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2002 | 2537 | 0.010 |
Why?
|
| Cysts | 1 | 1995 | 685 | 0.010 |
Why?
|
| Circadian Rhythm | 1 | 1981 | 2590 | 0.010 |
Why?
|
| RNA, Viral | 1 | 1977 | 2867 | 0.000 |
Why?
|
| Motor Skills | 1 | 1972 | 519 | 0.000 |
Why?
|
| Antigens, CD1 | 1 | 1991 | 434 | 0.000 |
Why?
|
| Erythrocytes | 1 | 1978 | 2412 | 0.000 |
Why?
|
| Dreams | 1 | 1969 | 145 | 0.000 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1989 | 826 | 0.000 |
Why?
|
| Chemistry | 1 | 1968 | 327 | 0.000 |
Why?
|
| beta-N-Acetylhexosaminidases | 1 | 1988 | 43 | 0.000 |
Why?
|
| Corticosterone | 1 | 1989 | 301 | 0.000 |
Why?
|
| Atropine | 1 | 1988 | 243 | 0.000 |
Why?
|
| Anemia, Aplastic | 1 | 1969 | 231 | 0.000 |
Why?
|
| Gastric Fistula | 1 | 1988 | 73 | 0.000 |
Why?
|
| DNA-Binding Proteins | 1 | 2004 | 9613 | 0.000 |
Why?
|
| Israel | 1 | 1969 | 726 | 0.000 |
Why?
|
| Hunger | 1 | 1989 | 207 | 0.000 |
Why?
|
| Uric Acid | 1 | 1973 | 809 | 0.000 |
Why?
|
| Thyroid Function Tests | 1 | 1987 | 289 | 0.000 |
Why?
|
| Rats, Inbred F344 | 1 | 1987 | 820 | 0.000 |
Why?
|
| Skin | 1 | 2000 | 4499 | 0.000 |
Why?
|
| Light | 1 | 1972 | 1358 | 0.000 |
Why?
|
| Gout | 1 | 1973 | 622 | 0.000 |
Why?
|
| Sciatic Nerve | 1 | 1989 | 627 | 0.000 |
Why?
|
| Peptides, Cyclic | 1 | 1988 | 390 | 0.000 |
Why?
|
| Photic Stimulation | 1 | 1972 | 1989 | 0.000 |
Why?
|
| Epilepsy, Temporal Lobe | 1 | 1969 | 390 | 0.000 |
Why?
|
| Sleep | 1 | 1980 | 4814 | 0.000 |
Why?
|
| Motor Cortex | 1 | 1972 | 1005 | 0.000 |
Why?
|
| Electric Stimulation | 1 | 1969 | 1736 | 0.000 |
Why?
|
| Thyrotropin | 1 | 1987 | 834 | 0.000 |
Why?
|
| Creatinine | 1 | 1969 | 1917 | 0.000 |
Why?
|
| Sexual Behavior | 1 | 1994 | 2193 | 0.000 |
Why?
|
| Lung Neoplasms | 1 | 1988 | 13489 | 0.000 |
Why?
|
| Genetic Testing | 1 | 1996 | 3591 | 0.000 |
Why?
|
| Lymphocyte Transfusion | 1 | 1984 | 236 | 0.000 |
Why?
|
| Graft Survival | 1 | 1993 | 3904 | 0.000 |
Why?
|
| Asthma | 1 | 1981 | 6266 | 0.000 |
Why?
|
| Immunoglobulin D | 1 | 1979 | 55 | 0.000 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 1989 | 2270 | 0.000 |
Why?
|
| Chemical Precipitation | 1 | 1979 | 174 | 0.000 |
Why?
|
| Convalescence | 1 | 1979 | 107 | 0.000 |
Why?
|
| Antigen-Antibody Complex | 1 | 1981 | 512 | 0.000 |
Why?
|
| Fluorescence | 1 | 1980 | 751 | 0.000 |
Why?
|
| Piperazines | 1 | 1988 | 2547 | 0.000 |
Why?
|
| Ultraviolet Rays | 1 | 1981 | 1100 | 0.000 |
Why?
|
| Histocompatibility Testing | 1 | 1977 | 726 | 0.000 |
Why?
|
| Cardiovascular Diseases | 1 | 1981 | 15652 | 0.000 |
Why?
|
| Psychotic Disorders | 1 | 1969 | 3275 | 0.000 |
Why?
|
| Microtubules | 1 | 1980 | 1063 | 0.000 |
Why?
|
| Drive | 1 | 1973 | 34 | 0.000 |
Why?
|
| Lactoglobulins | 1 | 1972 | 22 | 0.000 |
Why?
|
| Menarche | 1 | 1974 | 532 | 0.000 |
Why?
|
| Thyroglobulin | 1 | 1972 | 111 | 0.000 |
Why?
|
| Spectrophotometry | 1 | 1972 | 291 | 0.000 |
Why?
|
| Puberty | 1 | 1974 | 495 | 0.000 |
Why?
|
| Occupations | 1 | 1973 | 516 | 0.000 |
Why?
|
| Sleep Stages | 1 | 1974 | 705 | 0.000 |
Why?
|
| HIV Infections | 1 | 1996 | 17532 | 0.000 |
Why?
|
| Electromyography | 1 | 1972 | 1398 | 0.000 |
Why?
|
| Body Height | 1 | 1973 | 1562 | 0.000 |
Why?
|
| Interview, Psychological | 1 | 1969 | 810 | 0.000 |
Why?
|
| Motivation | 1 | 1973 | 2020 | 0.000 |
Why?
|
| Feeding Behavior | 1 | 1973 | 3208 | 0.000 |
Why?
|